Motif 268 (n=160)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0C4DFX4 | None | S2613 | ochoa | Snf2 related CREBBP activator protein | None |
A6NEL2 | SOWAHB | S106 | ochoa | Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B) | None |
A6NHT5 | HMX3 | S144 | ochoa | Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1) | Transcription factor involved in specification of neuronal cell types and which is required for inner ear and hypothalamus development. Binds to the 5'-CAAGTG-3' core sequence. Controls semicircular canal formation in the inner ear. Also required for hypothalamic/pituitary axis of the CNS (By similarity). {ECO:0000250}. |
A6NIX2 | WTIP | S29 | ochoa | Wilms tumor protein 1-interacting protein (WT1-interacting protein) | Adapter or scaffold protein which participates in the assembly of numerous protein complexes and is involved in several cellular processes such as cell fate determination, cytoskeletal organization, repression of gene transcription, cell-cell adhesion, cell differentiation, proliferation and migration. Positively regulates microRNA (miRNA)-mediated gene silencing. Negatively regulates Hippo signaling pathway and antagonizes phosphorylation of YAP1. Acts as a transcriptional corepressor for SNAI1 and SNAI2/SLUG-dependent repression of E-cadherin transcription. Acts as a hypoxic regulator by bridging an association between the prolyl hydroxylases and VHL enabling efficient degradation of HIF1A. In podocytes, may play a role in the regulation of actin dynamics and/or foot process cytoarchitecture (By similarity). In the course of podocyte injury, shuttles into the nucleus and acts as a transcription regulator that represses WT1-dependent transcription regulation, thereby translating changes in slit diaphragm structure into altered gene expression and a less differentiated phenotype. Involved in the organization of the basal body (By similarity). Involved in cilia growth and positioning (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:A9LS46, ECO:0000269|PubMed:20303269, ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22286099}. |
A6NKD9 | CCDC85C | S216 | ochoa | Coiled-coil domain-containing protein 85C | May play a role in cell-cell adhesion and epithelium development through its interaction with proteins of the beta-catenin family (Probable). May play an important role in cortical development, especially in the maintenance of radial glia (By similarity). {ECO:0000250|UniProtKB:E9Q6B2, ECO:0000305|PubMed:25009281}. |
A6NNZ2 | TUBB8B | S278 | ochoa | Tubulin beta 8B | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
E7EW31 | PROB1 | S218 | ochoa | Proline-rich basic protein 1 | None |
E9PAV3 | NACA | S917 | ochoa | Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC) | Cardiac- and muscle-specific transcription factor. May act to regulate the expression of genes involved in the development of myotubes. Plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration. Involved in the organized assembly of thick and thin filaments of myofibril sarcomeres (By similarity). {ECO:0000250|UniProtKB:P70670}. |
E9PAV3 | NACA | S1388 | ochoa | Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC) | Cardiac- and muscle-specific transcription factor. May act to regulate the expression of genes involved in the development of myotubes. Plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration. Involved in the organized assembly of thick and thin filaments of myofibril sarcomeres (By similarity). {ECO:0000250|UniProtKB:P70670}. |
M0R1B8 | None | S36 | ochoa | Uncharacterized protein | None |
O00221 | NFKBIE | S183 | ochoa | NF-kappa-B inhibitor epsilon (NF-kappa-BIE) (I-kappa-B-epsilon) (IkB-E) (IkB-epsilon) (IkappaBepsilon) | Sequesters NF-kappa-B transcription factor complexes in the cytoplasm, thereby inhibiting their activity (PubMed:9315679). Sequestered complexes include NFKB1-RELA (p50-p65) and NFKB1-REL (p50-c-Rel) complexes (PubMed:9135156, PubMed:9315679). Limits B-cell activation in response to pathogens, and also plays an important role in B-cell development (By similarity). {ECO:0000250|UniProtKB:O54910, ECO:0000269|PubMed:9135156, ECO:0000269|PubMed:9315679}. |
O00267 | SUPT5H | S797 | ochoa | Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein) | Component of the DRB sensitivity-inducing factor complex (DSIF complex), which regulates mRNA processing and transcription elongation by RNA polymerase II (PubMed:10075709, PubMed:10199401, PubMed:10421630, PubMed:10757782, PubMed:10912001, PubMed:11112772, PubMed:11553615, PubMed:12653964, PubMed:12718890, PubMed:15136722, PubMed:15380072, PubMed:9450929, PubMed:9857195). DSIF positively regulates mRNA capping by stimulating the mRNA guanylyltransferase activity of RNGTT/CAP1A (PubMed:10075709, PubMed:10421630, PubMed:10757782, PubMed:10912001, PubMed:11112772, PubMed:11553615, PubMed:12653964, PubMed:12718890, PubMed:15136722, PubMed:15380072, PubMed:9450929, PubMed:9857195). DSIF also acts cooperatively with the negative elongation factor complex (NELF complex) to enhance transcriptional pausing at sites proximal to the promoter (PubMed:10075709, PubMed:10199401, PubMed:10757782, PubMed:10912001, PubMed:11112772, PubMed:11553615, PubMed:12653964, PubMed:12718890, PubMed:15136722, PubMed:15380072, PubMed:9450929, PubMed:9857195). Transcriptional pausing may facilitate the assembly of an elongation competent RNA polymerase II complex (PubMed:10075709, PubMed:10199401, PubMed:10421630, PubMed:10757782, PubMed:10912001, PubMed:11112772, PubMed:11553615, PubMed:12653964, PubMed:12718890, PubMed:15136722, PubMed:15380072, PubMed:9450929, PubMed:9857195). DSIF and NELF promote pausing by inhibition of the transcription elongation factor TFIIS/S-II (PubMed:16214896). TFIIS/S-II binds to RNA polymerase II at transcription pause sites and stimulates the weak intrinsic nuclease activity of the enzyme (PubMed:16214896). Cleavage of blocked transcripts by RNA polymerase II promotes the resumption of transcription from the new 3' terminus and may allow repeated attempts at transcription through natural pause sites (PubMed:16214896). Following phosphorylation by CDK9, DSIF can also positively regulate transcriptional elongation (PubMed:16427012). Required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat (PubMed:10393184, PubMed:10454543, PubMed:11809800, PubMed:9514752). DSIF acts to suppress transcriptional pausing in transcripts derived from the HIV-1 LTR and blocks premature release of HIV-1 transcripts at terminator sequences (PubMed:11112772, PubMed:14701750). {ECO:0000269|PubMed:10075709, ECO:0000269|PubMed:10199401, ECO:0000269|PubMed:10393184, ECO:0000269|PubMed:10421630, ECO:0000269|PubMed:10454543, ECO:0000269|PubMed:10757782, ECO:0000269|PubMed:10912001, ECO:0000269|PubMed:11112772, ECO:0000269|PubMed:11553615, ECO:0000269|PubMed:11809800, ECO:0000269|PubMed:12653964, ECO:0000269|PubMed:12718890, ECO:0000269|PubMed:14701750, ECO:0000269|PubMed:15136722, ECO:0000269|PubMed:15380072, ECO:0000269|PubMed:16214896, ECO:0000269|PubMed:16427012, ECO:0000269|PubMed:9450929, ECO:0000269|PubMed:9514752, ECO:0000269|PubMed:9857195}. |
O14686 | KMT2D | S48 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O15061 | SYNM | S1049 | ochoa | Synemin (Desmuslin) | Type-VI intermediate filament (IF) which plays an important cytoskeletal role within the muscle cell cytoskeleton. It forms heteromeric IFs with desmin and/or vimentin, and via its interaction with cytoskeletal proteins alpha-dystrobrevin, dystrophin, talin-1, utrophin and vinculin, is able to link these heteromeric IFs to adherens-type junctions, such as to the costameres, neuromuscular junctions, and myotendinous junctions within striated muscle cells. {ECO:0000269|PubMed:11353857, ECO:0000269|PubMed:16777071, ECO:0000269|PubMed:18028034}. |
O15394 | NCAM2 | S786 | ochoa | Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) | May play important roles in selective fasciculation and zone-to-zone projection of the primary olfactory axons. |
O43166 | SIPA1L1 | S1078 | ochoa | Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1) | Stimulates the GTPase activity of RAP2A. Promotes reorganization of the actin cytoskeleton and recruits DLG4 to F-actin. Contributes to the regulation of dendritic spine morphogenesis (By similarity). {ECO:0000250}. |
O43426 | SYNJ1 | S1178 | ochoa | Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1) | Phosphatase that acts on various phosphoinositides, including phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate (PubMed:23804563, PubMed:27435091). Has a role in clathrin-mediated endocytosis (By similarity). Hydrolyzes PIP2 bound to actin regulatory proteins resulting in the rearrangement of actin filaments downstream of tyrosine kinase and ASH/GRB2 (By similarity). {ECO:0000250|UniProtKB:O18964, ECO:0000250|UniProtKB:Q62910, ECO:0000269|PubMed:23804563, ECO:0000269|PubMed:27435091}. |
O43593 | HR | S416 | ochoa | Lysine-specific demethylase hairless (EC 1.14.11.65) ([histone H3]-dimethyl-L-lysine(9) demethylase hairless) | Histone demethylase that specifically demethylates both mono- and dimethylated 'Lys-9' of histone H3. May act as a transcription regulator controlling hair biology (via targeting of collagens), neural activity, and cell cycle. {ECO:0000269|PubMed:24334705}. |
O43593 | HR | S833 | ochoa | Lysine-specific demethylase hairless (EC 1.14.11.65) ([histone H3]-dimethyl-L-lysine(9) demethylase hairless) | Histone demethylase that specifically demethylates both mono- and dimethylated 'Lys-9' of histone H3. May act as a transcription regulator controlling hair biology (via targeting of collagens), neural activity, and cell cycle. {ECO:0000269|PubMed:24334705}. |
O43683 | BUB1 | S331 | ochoa|psp | Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A) | Serine/threonine-protein kinase that performs 2 crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Has a key role in the assembly of checkpoint proteins at the kinetochore, being required for the subsequent localization of CENPF, BUB1B, CENPE and MAD2L1. Required for the kinetochore localization of PLK1. Required for centromeric enrichment of AUKRB in prometaphase. Plays an important role in defining SGO1 localization and thereby affects sister chromatid cohesion. Promotes the centromeric localization of TOP2A (PubMed:35044816). Acts as a substrate for anaphase-promoting complex or cyclosome (APC/C) in complex with its activator CDH1 (APC/C-Cdh1). Necessary for ensuring proper chromosome segregation and binding to BUB3 is essential for this function. Can regulate chromosome segregation in a kinetochore-independent manner. Can phosphorylate BUB3. The BUB1-BUB3 complex plays a role in the inhibition of APC/C when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1. Kinase activity is essential for inhibition of APC/CCDC20 and for chromosome alignment but does not play a major role in the spindle-assembly checkpoint activity. Mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:15525512, ECO:0000269|PubMed:15723797, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:17158872, ECO:0000269|PubMed:19487456, ECO:0000269|PubMed:20739936, ECO:0000269|PubMed:35044816}. |
O43815 | STRN | S376 | ochoa | Striatin | Calmodulin-binding scaffolding protein which is the center of the striatin-interacting phosphatase and kinase (STRIPAK) complexes (PubMed:18782753). STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (Probable). {ECO:0000269|PubMed:18782753, ECO:0000305|PubMed:26876214}. |
O60496 | DOK2 | S269 | ochoa | Docking protein 2 (Downstream of tyrosine kinase 2) (p56(dok-2)) | DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK2 may modulate the cellular proliferation induced by IL-4, as well as IL-2 and IL-3. May be involved in modulating Bcr-Abl signaling. Attenuates EGF-stimulated MAP kinase activation (By similarity). {ECO:0000250}. |
O60496 | DOK2 | S282 | ochoa | Docking protein 2 (Downstream of tyrosine kinase 2) (p56(dok-2)) | DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK2 may modulate the cellular proliferation induced by IL-4, as well as IL-2 and IL-3. May be involved in modulating Bcr-Abl signaling. Attenuates EGF-stimulated MAP kinase activation (By similarity). {ECO:0000250}. |
O75145 | PPFIA3 | S512 | ochoa | Liprin-alpha-3 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3) (PTPRF-interacting protein alpha-3) | May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates. {ECO:0000269|PubMed:9624153}. |
O75369 | FLNB | S1028 | ochoa | Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP) | Connects cell membrane constituents to the actin cytoskeleton. May promote orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Various interactions and localizations of isoforms affect myotube morphology and myogenesis. Isoform 6 accelerates muscle differentiation in vitro. |
O94989 | ARHGEF15 | S90 | ochoa | Rho guanine nucleotide exchange factor 15 (Ephexin-5) (E5) (Vsm-RhoGEF) | Specific GEF for RhoA activation. Does not activate RAC1 or CDC42. Regulates vascular smooth muscle contractility. Negatively regulates excitatory synapse development by suppressing the synapse-promoting activity of EPHB2. {ECO:0000269|PubMed:12775584}. |
O95180 | CACNA1H | S758 | ochoa | Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) | Voltage-sensitive calcium channel that gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group. A particularity of this type of channel is an opening at quite negative potentials, and a voltage-dependent inactivation (PubMed:27149520, PubMed:9670923, PubMed:9930755). T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle (Probable). They may also be involved in the modulation of firing patterns of neurons (PubMed:15048902). In the adrenal zona glomerulosa, participates in the signaling pathway leading to aldosterone production in response to either AGT/angiotensin II, or hyperkalemia (PubMed:25907736, PubMed:27729216). {ECO:0000269|PubMed:24277868, ECO:0000269|PubMed:25907736, ECO:0000269|PubMed:27149520, ECO:0000269|PubMed:27729216, ECO:0000269|PubMed:9670923, ECO:0000269|PubMed:9930755, ECO:0000305, ECO:0000305|PubMed:15048902}. |
P01106 | MYC | S77 | psp | Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64) | Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed:24940000, PubMed:25956029). Activates the transcription of growth-related genes (PubMed:24940000, PubMed:25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed:24940000, PubMed:25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808). {ECO:0000250|UniProtKB:P01108, ECO:0000269|PubMed:20010808, ECO:0000269|PubMed:24940000, ECO:0000269|PubMed:25956029}. |
P04350 | TUBB4A | S278 | ochoa | Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P07437 | TUBB | S278 | ochoa | Tubulin beta chain (Tubulin beta-5 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P10398 | ARAF | S165 | ochoa | Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks) | Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. Phosphorylates PFKFB2 (PubMed:36402789). {ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:36402789}.; FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. {ECO:0000269|PubMed:22609986}. |
P10636 | MAPT | S552 | ochoa | Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. {ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:32961270}. |
P11137 | MAP2 | S654 | ochoa | Microtubule-associated protein 2 (MAP-2) | The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules. |
P14866 | HNRNPL | S298 | ochoa | Heterogeneous nuclear ribonucleoprotein L (hnRNP L) | Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion. Exhibits a binding preference for CA-rich elements (PubMed:11809897, PubMed:22570490, PubMed:24164894, PubMed:25623890, PubMed:26051023). Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and associated with most nascent transcripts (PubMed:2687284). Associates, together with APEX1, to the negative calcium responsive element (nCaRE) B2 of the APEX2 promoter (PubMed:11809897). As part of a ribonucleoprotein complex composed at least of ZNF827, HNRNPK and the circular RNA circZNF827 that nucleates the complex on chromatin, may negatively regulate the transcription of genes involved in neuronal differentiation (PubMed:33174841). Regulates alternative splicing of a core group of genes involved in neuronal differentiation, likely by mediating H3K36me3-coupled transcription elongation and co-transcriptional RNA processing via interaction with CHD8. {ECO:0000269|PubMed:11809897, ECO:0000269|PubMed:22570490, ECO:0000269|PubMed:25623890, ECO:0000269|PubMed:26051023, ECO:0000269|PubMed:2687284, ECO:0000269|PubMed:33174841, ECO:0000269|PubMed:36537238}. |
P15408 | FOSL2 | S194 | ochoa | Fos-related antigen 2 (FRA-2) | Controls osteoclast survival and size (By similarity). As a dimer with JUN, activates LIF transcription (By similarity). Activates CEBPB transcription in PGE2-activated osteoblasts (By similarity). {ECO:0000250|UniProtKB:P47930, ECO:0000250|UniProtKB:P51145}. |
P15976 | GATA1 | S178 | psp | Erythroid transcription factor (Eryf1) (GATA-binding factor 1) (GATA-1) (GF-1) (NF-E1 DNA-binding protein) | Transcriptional activator or repressor which serves as a general switch factor for erythroid development (PubMed:35030251). It binds to DNA sites with the consensus sequence 5'-[AT]GATA[AG]-3' within regulatory regions of globin genes and of other genes expressed in erythroid cells. Activates the transcription of genes involved in erythroid differentiation of K562 erythroleukemia cells, including HBB, HBG1/2, ALAS2 and HMBS (PubMed:24245781). {ECO:0000269|PubMed:22235304, ECO:0000269|PubMed:24245781, ECO:0000269|PubMed:35030251}. |
P19793 | RXRA | S21 | ochoa|psp | Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) | Receptor for retinoic acid that acts as a transcription factor (PubMed:10874028, PubMed:11162439, PubMed:11915042, PubMed:37478846). Forms homo- or heterodimers with retinoic acid receptors (RARs) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes (PubMed:10195690, PubMed:11162439, PubMed:11915042, PubMed:16107141, PubMed:17761950, PubMed:18800767, PubMed:19167885, PubMed:28167758, PubMed:37478846). The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5 to regulate transcription (PubMed:10195690, PubMed:11162439, PubMed:11915042, PubMed:17761950, PubMed:28167758). The high affinity ligand for retinoid X receptors (RXRs) is 9-cis retinoic acid (PubMed:1310260). In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone deacetylation, chromatin condensation and transcriptional suppression (PubMed:20215566). On ligand binding, the corepressors dissociate from the receptors and coactivators are recruited leading to transcriptional activation (PubMed:20215566, PubMed:37478846, PubMed:9267036). Serves as a common heterodimeric partner for a number of nuclear receptors, such as RARA, RARB and PPARA (PubMed:10195690, PubMed:11915042, PubMed:28167758, PubMed:29021580). The RXRA/RARB heterodimer can act as a transcriptional repressor or transcriptional activator, depending on the RARE DNA element context (PubMed:29021580). The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes (PubMed:10195690). Together with RARA, positively regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1 signaling response to pulsatile shear stress in vascular endothelial cells (PubMed:28167758). Acts as an enhancer of RARA binding to RARE DNA element (PubMed:28167758). May facilitate the nuclear import of heterodimerization partners such as VDR and NR4A1 (PubMed:12145331, PubMed:15509776). Promotes myelin debris phagocytosis and remyelination by macrophages (PubMed:26463675). Plays a role in the attenuation of the innate immune system in response to viral infections, possibly by negatively regulating the transcription of antiviral genes such as type I IFN genes (PubMed:25417649). Involved in the regulation of calcium signaling by repressing ITPR2 gene expression, thereby controlling cellular senescence (PubMed:30216632). {ECO:0000269|PubMed:10195690, ECO:0000269|PubMed:10874028, ECO:0000269|PubMed:11162439, ECO:0000269|PubMed:11915042, ECO:0000269|PubMed:12145331, ECO:0000269|PubMed:1310260, ECO:0000269|PubMed:15509776, ECO:0000269|PubMed:16107141, ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:18800767, ECO:0000269|PubMed:19167885, ECO:0000269|PubMed:20215566, ECO:0000269|PubMed:25417649, ECO:0000269|PubMed:26463675, ECO:0000269|PubMed:28167758, ECO:0000269|PubMed:29021580, ECO:0000269|PubMed:30216632, ECO:0000269|PubMed:37478846, ECO:0000269|PubMed:9267036}. |
P21333 | FLNA | S2494 | ochoa | Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) | Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis. Plays a role in cell-cell contacts and adherens junctions during the development of blood vessels, heart and brain organs. Plays a role in platelets morphology through interaction with SYK that regulates ITAM- and ITAM-like-containing receptor signaling, resulting in by platelet cytoskeleton organization maintenance (By similarity). During the axon guidance process, required for growth cone collapse induced by SEMA3A-mediated stimulation of neurons (PubMed:25358863). {ECO:0000250, ECO:0000250|UniProtKB:Q8BTM8, ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:25358863}. |
P35611 | ADD1 | S358 | ochoa|psp | Alpha-adducin (Erythrocyte adducin subunit alpha) | Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to calmodulin. |
P35680 | HNF1B | S334 | ochoa | Hepatocyte nuclear factor 1-beta (HNF-1-beta) (HNF-1B) (Homeoprotein LFB3) (Transcription factor 2) (TCF-2) (Variant hepatic nuclear factor 1) (vHNF1) | Transcription factor that binds to the inverted palindrome 5'-GTTAATNATTAAC-3' (PubMed:17924661, PubMed:7900999). Binds to the FPC element in the cAMP regulatory unit of the PLAU gene (By similarity). Transcriptional activity is increased by coactivator PCBD1 (PubMed:24204001). {ECO:0000250|UniProtKB:Q03365, ECO:0000269|PubMed:17924661, ECO:0000269|PubMed:24204001, ECO:0000269|PubMed:7900999}. |
P41212 | ETV6 | S22 | ochoa|psp | Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel) | Transcriptional repressor; binds to the DNA sequence 5'-CCGGAAGT-3'. Plays a role in hematopoiesis and malignant transformation. {ECO:0000269|PubMed:25581430}. |
P43243 | MATR3 | S276 | ochoa | Matrin-3 | May play a role in transcription or may interact with other nuclear matrix proteins to form the internal fibrogranular network. In association with the SFPQ-NONO heteromer may play a role in nuclear retention of defective RNAs. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Binds to N6-methyladenosine (m6A)-containing mRNAs and contributes to MYC stability by binding to m6A-containing MYC mRNAs (PubMed:32245947). May bind to specific miRNA hairpins (PubMed:28431233). {ECO:0000269|PubMed:11525732, ECO:0000269|PubMed:28431233, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:32245947}. |
P48637 | GSS | S415 | ochoa | Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase) | Catalyzes the production of glutathione from gamma-glutamylcysteine and glycine in an ATP-dependent manner (PubMed:7646467, PubMed:9215686). Glutathione (gamma-glutamylcysteinylglycine, GSH) is the most abundant intracellular thiol in living aerobic cells and is required for numerous processes including the protection of cells against oxidative damage, amino acid transport, the detoxification of foreign compounds, the maintenance of protein sulfhydryl groups in a reduced state and acts as a cofactor for a number of enzymes (PubMed:10369661). Participates in ophthalmate biosynthesis in hepatocytes (By similarity). {ECO:0000250|UniProtKB:P51855, ECO:0000269|PubMed:7646467, ECO:0000269|PubMed:9215686, ECO:0000303|PubMed:10369661}. |
P50406 | HTR6 | S350 | psp | 5-hydroxytryptamine receptor 6 (5-HT-6) (5-HT6) (Serotonin receptor 6) | G-protein coupled receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone and a mitogen (PubMed:35714614, PubMed:36989299, PubMed:37327704, PubMed:8522988). Also has a high affinity for tricyclic psychotropic drugs (By similarity). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors (PubMed:35714614). HTR6 is coupled to G(s) G alpha proteins and mediates activation of adenylate cyclase activity (PubMed:35714614, PubMed:37327704). Controls pyramidal neurons migration during corticogenesis, through the regulation of CDK5 activity (By similarity). Is an activator of mTOR signaling (PubMed:23027611). {ECO:0000250|UniProtKB:P31388, ECO:0000250|UniProtKB:Q9R1C8, ECO:0000269|PubMed:23027611, ECO:0000269|PubMed:35714614, ECO:0000269|PubMed:36989299, ECO:0000269|PubMed:37327704, ECO:0000269|PubMed:8522988}. |
P51531 | SMARCA2 | S329 | ochoa | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SAMRCA2) (EC 3.6.4.-) (BRG1-associated factor 190B) (BAF190B) (Probable global transcription activator SNF2L2) (Protein brahma homolog) (hBRM) (SNF2-alpha) | ATPase involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically (PubMed:15075294, PubMed:22952240, PubMed:26601204). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). {ECO:0000250|UniProtKB:Q6DIC0, ECO:0000269|PubMed:15075294, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
P51608 | MECP2 | S164 | ochoa|psp | Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2) | Chromosomal protein that binds to methylated DNA. It can bind specifically to a single methyl-CpG pair. It is not influenced by sequences flanking the methyl-CpGs. Mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A. Binds both 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)-containing DNA, with a preference for 5-methylcytosine (5mC). {ECO:0000250|UniProtKB:Q9Z2D6}. |
P51617 | IRAK1 | S173 | psp | Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) | Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3. {ECO:0000269|PubMed:11397809, ECO:0000269|PubMed:12860405, ECO:0000269|PubMed:14684752, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:15465816, ECO:0000269|PubMed:15767370, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509}. |
P54259 | ATN1 | S661 | ochoa | Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein) | Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats. {ECO:0000250|UniProtKB:O35126, ECO:0000269|PubMed:10085113, ECO:0000269|PubMed:10973986}. |
P68371 | TUBB4B | S278 | ochoa | Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q08174 | PCDH1 | S962 | ochoa | Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42) | May be involved in cell-cell interaction processes and in cell adhesion. |
Q10586 | DBP | S156 | ochoa | D site-binding protein (Albumin D box-binding protein) (Albumin D-element-binding protein) (Tax-responsive enhancer element-binding protein 302) (TaxREB302) | This transcriptional activator recognizes and binds to the sequence 5'-RTTAYGTAAY-3' found in the promoter of genes such as albumin, CYP2A4 and CYP2A5. It is not essential for circadian rhythm generation, but modulates important clock output genes. May be a direct target for regulation by the circadian pacemaker component clock. May affect circadian period and sleep regulation. |
Q12830 | BPTF | S216 | ochoa | Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen) | Regulatory subunit of the ATP-dependent NURF-1 and NURF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:14609955, PubMed:28801535). The NURF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the NURF-5 ISWI chromatin remodeling complex (PubMed:28801535). Within the NURF-1 ISWI chromatin-remodeling complex, binds to the promoters of En1 and En2 to positively regulate their expression and promote brain development (PubMed:14609955). Histone-binding protein which binds to H3 tails trimethylated on 'Lys-4' (H3K4me3), which mark transcription start sites of active genes (PubMed:16728976, PubMed:16728978). Binds to histone H3 tails dimethylated on 'Lys-4' (H3K4Me2) to a lesser extent (PubMed:16728976, PubMed:16728978, PubMed:18042461). May also regulate transcription through direct binding to DNA or transcription factors (PubMed:10575013). {ECO:0000269|PubMed:10575013, ECO:0000269|PubMed:14609955, ECO:0000269|PubMed:16728976, ECO:0000269|PubMed:16728978, ECO:0000269|PubMed:18042461, ECO:0000269|PubMed:28801535}. |
Q13322 | GRB10 | S150 | ochoa|psp | Growth factor receptor-bound protein 10 (GRB10 adapter protein) (Insulin receptor-binding protein Grb-IR) | Adapter protein which modulates coupling of a number of cell surface receptor kinases with specific signaling pathways. Binds to, and suppress signals from, activated receptors tyrosine kinases, including the insulin (INSR) and insulin-like growth factor (IGF1R) receptors. The inhibitory effect can be achieved by 2 mechanisms: interference with the signaling pathway and increased receptor degradation. Delays and reduces AKT1 phosphorylation in response to insulin stimulation. Blocks association between INSR and IRS1 and IRS2 and prevents insulin-stimulated IRS1 and IRS2 tyrosine phosphorylation. Recruits NEDD4 to IGF1R, leading to IGF1R ubiquitination, increased internalization and degradation by both the proteasomal and lysosomal pathways. May play a role in mediating insulin-stimulated ubiquitination of INSR, leading to proteasomal degradation. Negatively regulates Wnt signaling by interacting with LRP6 intracellular portion and interfering with the binding of AXIN1 to LRP6. Positive regulator of the KDR/VEGFR-2 signaling pathway. May inhibit NEDD4-mediated degradation of KDR/VEGFR-2. {ECO:0000269|PubMed:12493740, ECO:0000269|PubMed:15060076, ECO:0000269|PubMed:16434550, ECO:0000269|PubMed:17376403}. |
Q13469 | NFATC2 | S73 | ochoa | Nuclear factor of activated T-cells, cytoplasmic 2 (NF-ATc2) (NFATc2) (NFAT pre-existing subunit) (NF-ATp) (T-cell transcription factor NFAT1) | Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2, IL-3, IL-4, TNF-alpha or GM-CSF (PubMed:15790681). Promotes invasive migration through the activation of GPC6 expression and WNT5A signaling pathway (PubMed:21871017). Is involved in the negative regulation of chondrogenesis (PubMed:35789258). Recruited by AKAP5 to ORAI1 pore-forming subunit of CRAC channels in Ca(2+) signaling microdomains where store-operated Ca(2+) influx is coupled to calmodulin and calcineurin signaling and activation of NFAT-dependent transcriptional responses. {ECO:0000250|UniProtKB:Q60591, ECO:0000269|PubMed:15790681, ECO:0000269|PubMed:21871017, ECO:0000269|PubMed:35789258}. |
Q13627 | DYRK1A | S555 | ochoa | Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.11.23) (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB) | Dual-specificity kinase which possesses both serine/threonine and tyrosine kinase activities (PubMed:20981014, PubMed:21127067, PubMed:23665168, PubMed:30773093, PubMed:8769099). Exhibits a substrate preference for proline at position P+1 and arginine at position P-3 (PubMed:23665168). Plays an important role in double-strand breaks (DSBs) repair following DNA damage (PubMed:31024071). Mechanistically, phosphorylates RNF169 and increases its ability to block accumulation of TP53BP1 at the DSB sites thereby promoting homologous recombination repair (HRR) (PubMed:30773093). Also acts as a positive regulator of transcription by acting as a CTD kinase that mediates phosphorylation of the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A (PubMed:25620562, PubMed:29849146). May play a role in a signaling pathway regulating nuclear functions of cell proliferation (PubMed:14500717). Modulates alternative splicing by phosphorylating the splice factor SRSF6 (By similarity). Has pro-survival function and negatively regulates the apoptotic process (By similarity). Promotes cell survival upon genotoxic stress through phosphorylation of SIRT1 (By similarity). This in turn inhibits p53/TP53 activity and apoptosis (By similarity). Phosphorylates SEPTIN4, SEPTIN5 and SF3B1 at 'Thr-434' (By similarity). {ECO:0000250|UniProtKB:Q61214, ECO:0000250|UniProtKB:Q63470, ECO:0000269|PubMed:14500717, ECO:0000269|PubMed:20981014, ECO:0000269|PubMed:21127067, ECO:0000269|PubMed:23665168, ECO:0000269|PubMed:25620562, ECO:0000269|PubMed:29849146, ECO:0000269|PubMed:30773093, ECO:0000269|PubMed:31024071, ECO:0000269|PubMed:8769099}. |
Q13885 | TUBB2A | S278 | ochoa | Tubulin beta-2A chain (Tubulin beta class IIa) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q14157 | UBAP2L | S454 | ochoa|psp | Ubiquitin-associated protein 2-like (Protein NICE-4) (RNA polymerase II degradation factor UBAP2L) | Recruits the ubiquitination machinery to RNA polymerase II for polyubiquitination, removal and degradation, when the transcription-coupled nucleotide excision repair (TC-NER) machinery fails to resolve DNA damage (PubMed:35633597). Plays an important role in the activity of long-term repopulating hematopoietic stem cells (LT-HSCs) (By similarity). Is a regulator of stress granule assembly, required for their efficient formation (PubMed:29395067, PubMed:35977029). Required for proper brain development and neocortex lamination (By similarity). {ECO:0000250|UniProtKB:Q80X50, ECO:0000269|PubMed:29395067, ECO:0000269|PubMed:35633597}. |
Q14315 | FLNC | S1050 | ochoa | Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) | Muscle-specific filamin, which plays a central role in sarcomere assembly and organization (PubMed:34405687). Critical for normal myogenesis, it probably functions as a large actin-cross-linking protein with structural functions at the Z lines in muscle cells. May be involved in reorganizing the actin cytoskeleton in response to signaling events (By similarity). {ECO:0000250|UniProtKB:Q8VHX6, ECO:0000269|PubMed:34405687}. |
Q14774 | HLX | S91 | ochoa | H2.0-like homeobox protein (Homeobox protein HB24) (Homeobox protein HLX1) | Transcription factor required for TBX21/T-bet-dependent maturation of Th1 cells as well as maintenance of Th1-specific gene expression. Involved in embryogenesis and hematopoiesis (By similarity). {ECO:0000250}. |
Q15717 | ELAVL1 | S202 | ochoa|psp | ELAV-like protein 1 (Hu-antigen R) (HuR) | RNA-binding protein that binds to the 3'-UTR region of mRNAs and increases their stability (PubMed:14517288, PubMed:18285462, PubMed:31358969). Involved in embryonic stem cell (ESC) differentiation: preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), stabilizing them, promoting ESC differentiation (By similarity). Has also been shown to be capable of binding to m6A-containing mRNAs and contributes to MYC stability by binding to m6A-containing MYC mRNAs (PubMed:32245947). Binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs (PubMed:14731398, PubMed:17632515, PubMed:18285462, PubMed:23519412, PubMed:8626503). Binds avidly to the AU-rich element in FOS and IL3/interleukin-3 mRNAs. In the case of the FOS AU-rich element, binds to a core element of 27 nucleotides that contain AUUUA, AUUUUA, and AUUUUUA motifs. Binds preferentially to the 5'-UUUU[AG]UUU-3' motif in vitro (PubMed:8626503). With ZNF385A, binds the 3'-UTR of p53/TP53 mRNA to control their nuclear export induced by CDKN2A. Hence, may regulate p53/TP53 expression and mediate in part the CDKN2A anti-proliferative activity. May also bind with ZNF385A the CCNB1 mRNA (By similarity). Increases the stability of the leptin mRNA harboring an AU-rich element (ARE) in its 3' UTR (PubMed:29180010). {ECO:0000250|UniProtKB:P70372, ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:14731398, ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:23519412, ECO:0000269|PubMed:29180010, ECO:0000269|PubMed:31358969, ECO:0000269|PubMed:32245947, ECO:0000269|PubMed:8626503}. |
Q16665 | HIF1A | S451 | ochoa|psp | Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) | Functions as a master transcriptional regulator of the adaptive response to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:18658046, PubMed:20624928, PubMed:22009797, PubMed:30125331, PubMed:9887100). Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:20624928, PubMed:22009797, PubMed:30125331, PubMed:9887100). Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease (PubMed:22009797). Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300 (PubMed:16543236, PubMed:9887100). Activity is enhanced by interaction with NCOA1 and/or NCOA2 (PubMed:10594042). Interaction with redox regulatory protein APEX1 seems to activate CTAD and potentiates activation by NCOA1 and CREBBP (PubMed:10202154, PubMed:10594042). Involved in the axonal distribution and transport of mitochondria in neurons during hypoxia (PubMed:19528298). {ECO:0000250|UniProtKB:Q61221, ECO:0000269|PubMed:10202154, ECO:0000269|PubMed:10594042, ECO:0000269|PubMed:11292861, ECO:0000269|PubMed:11566883, ECO:0000269|PubMed:15465032, ECO:0000269|PubMed:16543236, ECO:0000269|PubMed:16973622, ECO:0000269|PubMed:17610843, ECO:0000269|PubMed:18658046, ECO:0000269|PubMed:19528298, ECO:0000269|PubMed:20624928, ECO:0000269|PubMed:22009797, ECO:0000269|PubMed:30125331, ECO:0000269|PubMed:9887100}.; FUNCTION: (Microbial infection) Upon infection by human coronavirus SARS-CoV-2, is required for induction of glycolysis in monocytes and the consequent pro-inflammatory state (PubMed:32697943). In monocytes, induces expression of ACE2 and cytokines such as IL1B, TNF, IL6, and interferons (PubMed:32697943). Promotes human coronavirus SARS-CoV-2 replication and monocyte inflammatory response (PubMed:32697943). {ECO:0000269|PubMed:32697943}. |
Q2KHM9 | KIAA0753 | S190 | ochoa | Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein) | Involved in centriole duplication (PubMed:24613305, PubMed:26297806). Positively regulates CEP63 centrosomal localization (PubMed:24613305, PubMed:26297806). Required for WDR62 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:24613305, PubMed:26297806). May play a role in cilium assembly. {ECO:0000269|PubMed:24613305, ECO:0000269|PubMed:26297806, ECO:0000269|PubMed:28220259}. |
Q3ZCM7 | TUBB8 | S278 | ochoa | Tubulin beta-8 chain (Tubulin beta 8 class VIII) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. TUBB8 has a key role in meiotic spindle assembly and oocyte maturation (PubMed:26789871, PubMed:34509376). {ECO:0000269|PubMed:26789871, ECO:0000269|PubMed:34509376}. |
Q53GS9 | USP39 | S46 | ochoa | Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) | Deubiquitinating enzyme that plays a role in many cellular processes including cellular antiviral response, epithelial morphogenesis, DNA repair or B-cell development (PubMed:33127822, PubMed:34614178). Plays a role in pre-mRNA splicing as a component of the U4/U6-U5 tri-snRNP, one of the building blocks of the precatalytic spliceosome (PubMed:11350945, PubMed:26912367). Specifically regulates immunoglobulin gene rearrangement in a spliceosome-dependent manner, which involves modulating chromatin interactions at the Igh locus and therefore plays an essential role in B-cell development (By similarity). Regulates AURKB mRNA levels, and thereby plays a role in cytokinesis and in the spindle checkpoint (PubMed:18728397). Regulates apoptosis and G2/M cell cycle checkpoint in response to DNA damage by deubiquitinating and stabilizing CHK2 (PubMed:30771428). Also plays an important role in DNA repair by controlling the recruitment of XRCC4/LIG4 to DNA double-strand breaks for non-homologous end-joining repair (PubMed:34614178). Participates in antiviral activity by affecting the type I IFN signaling by stabilizing STAT1 and decreasing its 'Lys-6'-linked ubiquitination (PubMed:33127822). Contributes to non-canonical Wnt signaling during epidermal differentiation (By similarity). Acts as a negative regulator NF-kappa-B activation through deubiquitination of 'Lys-48'-linked ubiquitination of NFKBIA (PubMed:36651806). {ECO:0000250|UniProtKB:Q3TIX9, ECO:0000269|PubMed:11350945, ECO:0000269|PubMed:18728397, ECO:0000269|PubMed:26912367, ECO:0000269|PubMed:30771428, ECO:0000269|PubMed:33127822, ECO:0000269|PubMed:34614178, ECO:0000269|PubMed:36651806}. |
Q58EX7 | PLEKHG4 | S64 | ochoa | Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1) | Possible role in intracellular signaling and cytoskeleton dynamics at the Golgi. |
Q5JTC6 | AMER1 | S286 | ochoa | APC membrane recruitment protein 1 (Amer1) (Protein FAM123B) (Wilms tumor gene on the X chromosome protein) | Regulator of the canonical Wnt signaling pathway. Acts by specifically binding phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), translocating to the cell membrane and interacting with key regulators of the canonical Wnt signaling pathway, such as components of the beta-catenin destruction complex. Acts both as a positive and negative regulator of the Wnt signaling pathway, depending on the context: acts as a positive regulator by promoting LRP6 phosphorylation. Also acts as a negative regulator by acting as a scaffold protein for the beta-catenin destruction complex and promoting stabilization of Axin at the cell membrane. Promotes CTNNB1 ubiquitination and degradation. Involved in kidney development. {ECO:0000269|PubMed:17510365, ECO:0000269|PubMed:17925383, ECO:0000269|PubMed:19416806, ECO:0000269|PubMed:21304492, ECO:0000269|PubMed:21498506}. |
Q5JTD0 | TJAP1 | S491 | ochoa | Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4) | Plays a role in regulating the structure of the Golgi apparatus. {ECO:0000250|UniProtKB:Q9DCD5}. |
Q5SXM2 | SNAPC4 | S1224 | ochoa | snRNA-activating protein complex subunit 4 (SNAPc subunit 4) (Proximal sequence element-binding transcription factor subunit alpha) (PSE-binding factor subunit alpha) (PTF subunit alpha) (snRNA-activating protein complex 190 kDa subunit) (SNAPc 190 kDa subunit) | Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box. {ECO:0000269|PubMed:12621023, ECO:0000269|PubMed:9418884}. |
Q5T7B8 | KIF24 | S997 | ochoa | Kinesin-like protein KIF24 | Microtubule-dependent motor protein that acts as a negative regulator of ciliogenesis by mediating recruitment of CCP110 to mother centriole in cycling cells, leading to restrict nucleation of cilia at centrioles. Mediates depolymerization of microtubules of centriolar origin, possibly to suppress aberrant cilia formation (PubMed:21620453). Following activation by NEK2 involved in disassembly of primary cilium during G2/M phase but does not disassemble fully formed ciliary axonemes. As cilium assembly and disassembly is proposed to coexist in a dynamic equilibrium may suppress nascent cilium assembly and, potentially, ciliar re-assembly in cells that have already disassembled their cilia ensuring the completion of cilium removal in the later stages of the cell cycle (PubMed:26290419). Plays an important role in recruiting MPHOSPH9, a negative regulator of cilia formation to the distal end of mother centriole (PubMed:30375385). {ECO:0000269|PubMed:21620453, ECO:0000269|PubMed:26290419, ECO:0000269|PubMed:30375385}. |
Q641Q2 | WASHC2A | S1008 | ochoa | WASH complex subunit 2A | Acts at least in part as component of the WASH core complex whose assembly at the surface of endosomes inhibits WASH nucleation-promoting factor (NPF) activity in recruiting and activating the Arp2/3 complex to induce actin polymerization and is involved in the fission of tubules that serve as transport intermediates during endosome sorting. Mediates the recruitment of the WASH core complex to endosome membranes via binding to phospholipids and VPS35 of the retromer CSC. Mediates the recruitment of the F-actin-capping protein dimer to the WASH core complex probably promoting localized F-actin polymerization needed for vesicle scission. Via its C-terminus binds various phospholipids, most strongly phosphatidylinositol 4-phosphate (PtdIns-(4)P), phosphatidylinositol 5-phosphate (PtdIns-(5)P) and phosphatidylinositol 3,5-bisphosphate (PtdIns-(3,5)P2). Involved in the endosome-to-plasma membrane trafficking and recycling of SNX27-retromer-dependent cargo proteins, such as GLUT1. Required for the association of DNAJC13, ENTR1, ANKRD50 with retromer CSC subunit VPS35. Required for the endosomal recruitment of CCC complex subunits COMMD1 and CCDC93 as well as the retriever complex subunit VPS35L. {ECO:0000269|PubMed:25355947, ECO:0000269|PubMed:28892079}. |
Q68EM7 | ARHGAP17 | S561 | ochoa | Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) | Rho GTPase-activating protein involved in the maintenance of tight junction by regulating the activity of CDC42, thereby playing a central role in apical polarity of epithelial cells. Specifically acts as a GTPase activator for the CDC42 GTPase by converting it to an inactive GDP-bound state. The complex formed with AMOT acts by regulating the uptake of polarity proteins at tight junctions, possibly by deciding whether tight junction transmembrane proteins are recycled back to the plasma membrane or sent elsewhere. Participates in the Ca(2+)-dependent regulation of exocytosis, possibly by catalyzing GTPase activity of Rho family proteins and by inducing the reorganization of the cortical actin filaments. Acts as a GTPase activator in vitro for RAC1. {ECO:0000269|PubMed:11431473, ECO:0000269|PubMed:16678097}. |
Q6DN90 | IQSEC1 | S417 | ochoa | IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2) | Guanine nucleotide exchange factor for ARF1 and ARF6 (PubMed:11226253, PubMed:24058294). Guanine nucleotide exchange factor activity is enhanced by lipid binding (PubMed:24058294). Accelerates GTP binding by ARFs of all three classes. Guanine nucleotide exchange protein for ARF6, mediating internalization of beta-1 integrin (PubMed:16461286). Involved in neuronal development (Probable). In neurons, plays a role in the control of vesicle formation by endocytoc cargo. Upon long term depression, interacts with GRIA2 and mediates the activation of ARF6 to internalize synaptic AMPAR receptors (By similarity). {ECO:0000250|UniProtKB:A0A0G2JUG7, ECO:0000269|PubMed:11226253, ECO:0000269|PubMed:16461286, ECO:0000269|PubMed:24058294, ECO:0000305|PubMed:31607425}. |
Q6EKJ0 | GTF2IRD2B | S205 | ochoa | General transcription factor II-I repeat domain-containing protein 2B (GTF2I repeat domain-containing protein 2B) (Transcription factor GTF2IRD2-beta) | None |
Q6IN85 | PPP4R3A | S771 | ochoa | Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1) | Regulatory subunit of serine/threonine-protein phosphatase 4. May regulate the activity of PPP4C at centrosomal microtubule organizing centers. The PPP4C-PPP4R2-PPP4R3A PP4 complex specifically dephosphorylates H2AX phosphorylated on 'Ser-140' (gamma-H2AX) generated during DNA replication and required for DNA DSB repair. {ECO:0000269|PubMed:18614045}. |
Q6P0Q8 | MAST2 | S191 | ochoa | Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) | Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation (By similarity). {ECO:0000250}. |
Q6P474 | PDXDC2P | S400 | ochoa | Putative pyridoxal-dependent decarboxylase domain-containing protein 2 (EC 4.1.1.-) (pyridoxal-dependent decarboxylase domain-containing 2 pseudogene) | None |
Q6P996 | PDXDC1 | S401 | ochoa | Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-) | None |
Q6UB99 | ANKRD11 | S1891 | ochoa | Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) | Chromatin regulator which modulates histone acetylation and gene expression in neural precursor cells (By similarity). May recruit histone deacetylases (HDACs) to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation (PubMed:15184363). Has a role in proliferation and development of cortical neural precursors (PubMed:25556659). May also regulate bone homeostasis (By similarity). {ECO:0000250|UniProtKB:E9Q4F7, ECO:0000269|PubMed:15184363, ECO:0000269|PubMed:25556659}. |
Q6ZRI6 | C15orf39 | S116 | ochoa | Uncharacterized protein C15orf39 | None |
Q6ZRS2 | SRCAP | S2790 | ochoa | Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator) | Catalytic component of the SRCAP complex which mediates the ATP-dependent exchange of histone H2AZ/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling. Acts as a coactivator for CREB-mediated transcription, steroid receptor-mediated transcription, and Notch-mediated transcription. {ECO:0000269|PubMed:10347196, ECO:0000269|PubMed:11522779, ECO:0000269|PubMed:14500758, ECO:0000269|PubMed:16024792, ECO:0000269|PubMed:16634648, ECO:0000269|PubMed:17617668}. |
Q7RTP6 | MICAL3 | S1384 | ochoa | [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) | Monooxygenase that promotes depolymerization of F-actin by mediating oxidation of specific methionine residues on actin to form methionine-sulfoxide, resulting in actin filament disassembly and preventing repolymerization. In the absence of actin, it also functions as a NADPH oxidase producing H(2)O(2). Seems to act as Rab effector protein and plays a role in vesicle trafficking. Involved in exocytic vesicles tethering and fusion: the monooxygenase activity is required for this process and implicates RAB8A associated with exocytotic vesicles. Required for cytokinesis. Contributes to stabilization and/or maturation of the intercellular bridge independently of its monooxygenase activity. Promotes recruitment of Rab8 and ERC1 to the intercellular bridge, and together these proteins are proposed to function in timely abscission. {ECO:0000269|PubMed:21596566, ECO:0000269|PubMed:24440334}. |
Q7Z2Z1 | TICRR | S1433 | ochoa | Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein) | Regulator of DNA replication and S/M and G2/M checkpoints. Regulates the triggering of DNA replication initiation via its interaction with TOPBP1 by participating in CDK2-mediated loading of CDC45L onto replication origins. Required for the transition from pre-replication complex (pre-RC) to pre-initiation complex (pre-IC). Required to prevent mitotic entry after treatment with ionizing radiation. {ECO:0000269|PubMed:20116089}. |
Q7Z7G8 | VPS13B | S1263 | ochoa | Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) | Mediates the transfer of lipids between membranes at organelle contact sites (By similarity). Binds phosphatidylinositol 3-phosphate (By similarity). Functions as a tethering factor in the slow endocytic recycling pathway, to assist traffic between early and recycling endosomes (PubMed:24334764, PubMed:30962439, PubMed:32375900). Involved in the transport of proacrosomal vesicles to the nuclear dense lamina (NDL) during spermatid development (By similarity). Plays a role in the assembly of the Golgi apparatus, possibly by mediating trafficking to the Golgi membrane (PubMed:21865173). Plays a role in the development of the nervous system, and may be required for neuron projection development (PubMed:25492866, PubMed:32560273). May also play a role during adipose tissue development (PubMed:26358774). Required for maintenance of the ocular lens (By similarity). {ECO:0000250|UniProtKB:Q07878, ECO:0000250|UniProtKB:Q80TY5, ECO:0000269|PubMed:21865173, ECO:0000269|PubMed:24334764, ECO:0000269|PubMed:26358774, ECO:0000269|PubMed:30962439, ECO:0000269|PubMed:32375900, ECO:0000269|PubMed:32560273, ECO:0000305|PubMed:25492866, ECO:0000305|PubMed:32560273}. |
Q86TI0 | TBC1D1 | S695 | ochoa | TBC1 domain family member 1 | May act as a GTPase-activating protein for Rab family protein(s). May play a role in the cell cycle and differentiation of various tissues. Involved in the trafficking and translocation of GLUT4-containing vesicles and insulin-stimulated glucose uptake into cells (By similarity). {ECO:0000250}. |
Q86UP8 | GTF2IRD2 | S205 | ochoa | General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein 2A) (Transcription factor GTF2IRD2-alpha) | None |
Q86UU1 | PHLDB1 | S461 | ochoa | Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha) | None |
Q86UY5 | FAM83A | S357 | ochoa | Protein FAM83A (Tumor antigen BJ-TSA-9) (Tumor-specific gene expressed in prostate protein) | Involved in mitochondrial maintenance during adipogenesis. May be acting by playing a role in the maintenance of normal mitochondrial function. {ECO:0000250|UniProtKB:Q8K2P2}. |
Q86WB0 | ZC3HC1 | S161 | ochoa | Zinc finger C3HC-type protein 1 (Nuclear-interacting partner of ALK) (hNIPA) (Nuclear-interacting partner of anaplastic lymphoma kinase) | Required for proper positioning of a substantial amount of TPR at the nuclear basket (NB) through interaction with TPR. {ECO:0000269|PubMed:34440706}. |
Q86XL3 | ANKLE2 | S866 | ochoa | Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) | Involved in mitotic nuclear envelope reassembly by promoting dephosphorylation of BAF/BANF1 during mitotic exit (PubMed:22770216). Coordinates the control of BAF/BANF1 dephosphorylation by inhibiting VRK1 kinase and promoting dephosphorylation of BAF/BANF1 by protein phosphatase 2A (PP2A), thereby facilitating nuclear envelope assembly (PubMed:22770216). May regulate nuclear localization of VRK1 in non-dividing cells (PubMed:31735666). It is unclear whether it acts as a real PP2A regulatory subunit or whether it is involved in recruitment of the PP2A complex (PubMed:22770216). Involved in brain development (PubMed:25259927). {ECO:0000269|PubMed:22770216, ECO:0000269|PubMed:25259927, ECO:0000269|PubMed:31735666}. |
Q8IU68 | TMC8 | S683 | ochoa | Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2) | Acts as a regulatory protein involved in the regulation of numerous cellular processes (PubMed:18158319, PubMed:23429285, PubMed:30068544, PubMed:32917726). Together with its homolog TMC6/EVER1, forms a complex with calcium-binding protein CIB1 in lymphocytes and keratynocytes where TMC6 and TMC8 stabilize CIB1 levels and reciprocally (PubMed:30068544, PubMed:32917726). Together with TMC6, also forms a complex with and activates zinc transporter ZNT1 at the ER membrane of keratynocytes, thereby facilitating zinc uptake into the ER (PubMed:18158319). Also inhibits receptor-mediated calcium release from ER stores and calcium activated and volume regulated chloride channels (PubMed:25220380). Down-regulates the activity of transcription factors induced by zinc and cytokines (PubMed:18158319). Also sequesters TRADD which impairs the recruitment of TRAF2 and RIPK1 in the pro-survival complex I and promotes proapoptotic complex II formation, and may therefore be involved in TNF-induced cell death/survival decisions (PubMed:23429285). {ECO:0000269|PubMed:18158319, ECO:0000269|PubMed:23429285, ECO:0000269|PubMed:25220380, ECO:0000269|PubMed:30068544, ECO:0000269|PubMed:32917726}. |
Q8IUG5 | MYO18B | S2236 | ochoa | Unconventional myosin-XVIIIb | May be involved in intracellular trafficking of the muscle cell when in the cytoplasm, whereas entering the nucleus, may be involved in the regulation of muscle specific genes. May play a role in the control of tumor development and progression; restored MYO18B expression in lung cancer cells suppresses anchorage-independent growth. |
Q8IUW3 | SPATA2L | S252 | ochoa | Spermatogenesis-associated protein 2-like protein (SPATA2-like protein) | None |
Q8IUW5 | RELL1 | S157 | ochoa | RELT-like protein 1 | Induces activation of MAPK14/p38 cascade, when overexpressed (PubMed:28688764). Induces apoptosis, when overexpressed (PubMed:19969290). {ECO:0000269|PubMed:19969290, ECO:0000269|PubMed:28688764}. |
Q8IV48 | ERI1 | S21 | ochoa | 3'-5' exoribonuclease 1 (EC 3.1.13.1) (3'-5' exonuclease ERI1) (Eri-1 homolog) (Histone mRNA 3'-end-specific exoribonuclease) (Histone mRNA 3'-exonuclease 1) (Protein 3'hExo) (HEXO) | RNA exonuclease that binds to the 3'-end of histone mRNAs and degrades them, suggesting that it plays an essential role in histone mRNA decay after replication (PubMed:14536070, PubMed:16912046, PubMed:17135487, PubMed:37352860). A 2' and 3'-hydroxyl groups at the last nucleotide of the histone 3'-end is required for efficient 3'-end histone mRNA exonuclease activity and degradation of RNA substrates (PubMed:14536070, PubMed:16912046, PubMed:17135487). Also able to degrade the 3'-overhangs of short interfering RNAs (siRNAs) in vitro, suggesting a possible role as regulator of RNA interference (RNAi) (PubMed:14961122). Required for binding the 5'-ACCCA-3' sequence present in stem-loop structure (PubMed:14536070, PubMed:16912046). Able to bind other mRNAs (PubMed:14536070, PubMed:16912046). Required for 5.8S rRNA 3'-end processing (PubMed:37352860). Also binds to 5.8s ribosomal RNA (By similarity). Binds with high affinity to the stem-loop structure of replication-dependent histone pre-mRNAs (PubMed:14536070, PubMed:16912046, PubMed:17135487). In vitro, does not have sequence specificity (PubMed:17135487). In vitro, has weak DNA exonuclease activity (PubMed:17135487). In vitro, shows biphasic kinetics such that there is rapid hydrolysis of the last three unpaired RNA nucleotides in the 39 flanking sequence followed by a much slower cleavage through the stem that occurs over a longer incubation period in the order of hours (PubMed:17135487). ERI1-mediated RNA metabolism plays a key role in chondrogenesis (PubMed:37352860). {ECO:0000250|UniProtKB:Q7TMF2, ECO:0000269|PubMed:14536070, ECO:0000269|PubMed:14961122, ECO:0000269|PubMed:16912046, ECO:0000269|PubMed:17135487, ECO:0000269|PubMed:37352860}. |
Q8IV61 | RASGRP3 | S563 | ochoa | Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1) | Guanine nucleotide exchange factor (GEF) for Ras and Rap1. {ECO:0000269|PubMed:10934204}. |
Q8IVF2 | AHNAK2 | S4897 | ochoa | Protein AHNAK2 | None |
Q8IXT5 | RBM12B | S874 | ochoa | RNA-binding protein 12B (RNA-binding motif protein 12B) | None |
Q8IYA7 | MKX | S36 | ochoa | Homeobox protein Mohawk | May act as a morphogenetic regulator of cell adhesion. {ECO:0000250}. |
Q8IYB3 | SRRM1 | S393 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8N2Y8 | RUSC2 | S536 | ochoa | AP-4 complex accessory subunit RUSC2 (Interacting protein of Rab1) (Iporin) (RUN and SH3 domain-containing protein 2) | Associates with the adapter-like complex 4 (AP-4) and may therefore play a role in vesicular trafficking of proteins at the trans-Golgi network. {ECO:0000269|PubMed:30262884}. |
Q8NCG7 | DAGLB | S570 | ochoa | Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta) | Lipase that catalyzes the hydrolysis of arachidonic acid (AA)-esterified diacylglycerols (DAGs) to produce the principal endocannabinoid, 2-arachidonoylglycerol (2-AG) which can be further cleaved by downstream enzymes to release arachidonic acid (AA) for cyclooxygenase (COX)-mediated eicosanoid production (PubMed:14610053). Preferentially hydrolyzes DAGs at the sn-1 position in a calcium-dependent manner and has negligible activity against other lipids including monoacylglycerols and phospholipids (PubMed:14610053). Plays a key role in the regulation of 2-AG and AA pools utilized by COX1/2 to generate lipid mediators of macrophage and microglia inflammatory responses. Also functions as a polyunsaturated fatty acids-specific triacylglycerol lipase in macrophages. Plays an important role to support the metabolic and signaling demands of macrophages (By similarity). {ECO:0000250|UniProtKB:Q91WC9, ECO:0000269|PubMed:14610053}. |
Q8NDX1 | PSD4 | S448 | ochoa | PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein) | Guanine nucleotide exchange factor for ARF6 and ARL14/ARF7. Through ARL14 activation, controls the movement of MHC class II-containing vesicles along the actin cytoskeleton in dendritic cells. Involved in membrane recycling. Interacts with several phosphatidylinositol phosphate species, including phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:12082148, ECO:0000269|PubMed:21458045}. |
Q8NEZ4 | KMT2C | S2946 | ochoa | Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:22266653, PubMed:24081332, PubMed:25561738). Likely plays a redundant role with KMT2D in enriching H3K4me1 mark on primed and active enhancer elements (PubMed:24081332). {ECO:0000269|PubMed:22266653, ECO:0000269|PubMed:24081332, ECO:0000269|PubMed:25561738}. |
Q8NHM5 | KDM2B | S1018 | ochoa | Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B) | Histone demethylase that demethylates 'Lys-4' and 'Lys-36' of histone H3, thereby playing a central role in histone code (PubMed:16362057, PubMed:17994099, PubMed:26237645). Preferentially demethylates trimethylated H3 'Lys-4' and dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36' (PubMed:16362057, PubMed:17994099, PubMed:26237645). Preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation (PubMed:16362057, PubMed:17994099). May also serve as a substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex (Probable). {ECO:0000269|PubMed:16362057, ECO:0000269|PubMed:17994099, ECO:0000269|PubMed:26237645, ECO:0000305}. |
Q8TAP8 | PPP1R35 | S52 | ochoa | Protein phosphatase 1 regulatory subunit 35 | During centriole duplication, plays a role in the centriole elongation by promoting the recruitment of the microtubule-binding elongation machinery through its interaction with RTTN, leading to the centriole to centrosome conversion (PubMed:30168418, PubMed:30230954). In addition, may play a role in the primary cilia assembly (By similarity). {ECO:0000250|UniProtKB:Q9D8C8, ECO:0000269|PubMed:30168418, ECO:0000269|PubMed:30230954}. |
Q8TB72 | PUM2 | S182 | ochoa | Pumilio homolog 2 (Pumilio-2) | Sequence-specific RNA-binding protein that acts as a post-transcriptional repressor by binding the 3'-UTR of mRNA targets. Binds to an RNA consensus sequence, the Pumilio Response Element (PRE), 5'-UGUANAUA-3', that is related to the Nanos Response Element (NRE) (, PubMed:21397187). Mediates post-transcriptional repression of transcripts via different mechanisms: acts via direct recruitment of the CCR4-POP2-NOT deadenylase leading to translational inhibition and mRNA degradation (PubMed:22955276). Also mediates deadenylation-independent repression by promoting accessibility of miRNAs (PubMed:18776931, PubMed:22345517). Acts as a post-transcriptional repressor of E2F3 mRNAs by binding to its 3'-UTR and facilitating miRNA regulation (PubMed:22345517). Plays a role in cytoplasmic sensing of viral infection (PubMed:25340845). Represses a program of genes necessary to maintain genomic stability such as key mitotic, DNA repair and DNA replication factors. Its ability to repress those target mRNAs is regulated by the lncRNA NORAD (non-coding RNA activated by DNA damage) which, due to its high abundance and multitude of PUMILIO binding sites, is able to sequester a significant fraction of PUM1 and PUM2 in the cytoplasm (PubMed:26724866). May regulate DCUN1D3 mRNA levels (PubMed:25349211). May support proliferation and self-renewal of stem cells. Binds specifically to miRNA MIR199A precursor, with PUM1, regulates miRNA MIR199A expression at a postranscriptional level (PubMed:28431233). {ECO:0000269|PubMed:18776931, ECO:0000269|PubMed:21397187, ECO:0000269|PubMed:22345517, ECO:0000269|PubMed:22955276, ECO:0000269|PubMed:25340845, ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:26724866, ECO:0000269|PubMed:28431233}. |
Q8TD16 | BICD2 | S606 | ochoa | Protein bicaudal D homolog 2 (Bic-D 2) | Acts as an adapter protein linking the dynein motor complex to various cargos and converts dynein from a non-processive to a highly processive motor in the presence of dynactin. Facilitates and stabilizes the interaction between dynein and dynactin and activates dynein processivity (the ability to move along a microtubule for a long distance without falling off the track) (PubMed:25814576). Facilitates the binding of RAB6A to the Golgi by stabilizing its GTP-bound form. Regulates coat complex coatomer protein I (COPI)-independent Golgi-endoplasmic reticulum transport via its interaction with RAB6A and recruitment of the dynein-dynactin motor complex (PubMed:25962623). Contributes to nuclear and centrosomal positioning prior to mitotic entry through regulation of both dynein and kinesin-1. During G2 phase of the cell cycle, associates with RANBP2 at the nuclear pores and recruits dynein and dynactin to the nuclear envelope to ensure proper positioning of the nucleus relative to centrosomes prior to the onset of mitosis (By similarity). {ECO:0000250|UniProtKB:Q921C5, ECO:0000269|PubMed:25814576, ECO:0000269|PubMed:25962623}. |
Q8WUA7 | TBC1D22A | S21 | ochoa | TBC1 domain family member 22A | May act as a GTPase-activating protein for Rab family protein(s). {ECO:0000250}. |
Q8WUF5 | PPP1R13L | S110 | ochoa | RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein) | Regulator that plays a central role in regulation of apoptosis and transcription via its interaction with NF-kappa-B and p53/TP53 proteins. Blocks transcription of HIV-1 virus by inhibiting the action of both NF-kappa-B and SP1. Also inhibits p53/TP53 function, possibly by preventing the association between p53/TP53 and ASPP1 or ASPP2, and therefore suppressing the subsequent activation of apoptosis (PubMed:12524540). Is involved in NF-kappa-B dependent negative regulation of inflammatory response (PubMed:28069640). {ECO:0000269|PubMed:10336463, ECO:0000269|PubMed:12134007, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:15489900, ECO:0000269|PubMed:28069640}. |
Q8WUM0 | NUP133 | S50 | ochoa|psp | Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) | Involved in poly(A)+ RNA transport. Involved in nephrogenesis (PubMed:30179222). {ECO:0000269|PubMed:11684705, ECO:0000269|PubMed:30179222}. |
Q8WWM7 | ATXN2L | S396 | ochoa | Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein) | Involved in the regulation of stress granule and P-body formation. {ECO:0000269|PubMed:23209657}. |
Q8WXD9 | CASKIN1 | S1257 | ochoa | Caskin-1 (CASK-interacting protein 1) | May link the scaffolding protein CASK to downstream intracellular effectors. {ECO:0000250}. |
Q8WYR1 | PIK3R5 | S468 | ochoa | Phosphoinositide 3-kinase regulatory subunit 5 (PI3-kinase regulatory subunit 5) (PI3-kinase p101 subunit) (Phosphatidylinositol 4,5-bisphosphate 3-kinase regulatory subunit) (PtdIns-3-kinase regulatory subunit) (Protein FOAP-2) (PtdIns-3-kinase p101) (p101-PI3K) | Regulatory subunit of the PI3K gamma complex. Required for recruitment of the catalytic subunit to the plasma membrane via interaction with beta-gamma G protein dimers. Required for G protein-mediated activation of PIK3CG (By similarity). {ECO:0000250}. |
Q92835 | INPP5D | S1039 | ochoa | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (EC 3.1.3.86) (Inositol polyphosphate-5-phosphatase D) (EC 3.1.3.56) (Inositol polyphosphate-5-phosphatase of 145 kDa) (SIP-145) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (SH2 domain-containing inositol 5'-phosphatase 1) (SH2 domain-containing inositol phosphatase 1) (SHIP-1) (p150Ship) (hp51CN) | Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways (PubMed:10764818, PubMed:8723348, PubMed:8769125). Able also to hydrolyzes the 5-phosphate of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P3) and inositol 1,3,4,5-tetrakisphosphate (PubMed:10764818, PubMed:8769125, PubMed:9108392). Acts as a negative regulator of B-cell antigen receptor signaling. Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Acts as a negative regulator of myeloid cell proliferation/survival and chemotaxis, mast cell degranulation, immune cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and JNK signaling in B-cells. Regulates proliferation of osteoclast precursors, macrophage programming, phagocytosis and activation and is required for endotoxin tolerance. Involved in the control of cell-cell junctions, CD32a signaling in neutrophils and modulation of EGF-induced phospholipase C activity (PubMed:16682172). Key regulator of neutrophil migration, by governing the formation of the leading edge and polarization required for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells. Mediates the activin/TGF-beta-induced apoptosis through its Smad-dependent expression. {ECO:0000269|PubMed:10764818, ECO:0000269|PubMed:12421919, ECO:0000269|PubMed:16682172, ECO:0000269|PubMed:8723348, ECO:0000269|PubMed:8769125, ECO:0000269|PubMed:9108392}. |
Q96F45 | ZNF503 | S102 | ochoa | Zinc finger protein 503 | May function as a transcriptional repressor. {ECO:0000250}. |
Q96FS4 | SIPA1 | S884 | ochoa | Signal-induced proliferation-associated protein 1 (Sipa-1) (GTPase-activating protein Spa-1) (p130 SPA-1) | GTPase activator for the nuclear Ras-related regulatory proteins Rap1 and Rap2 in vitro, converting them to the putatively inactive GDP-bound state (PubMed:9346962). Affects cell cycle progression (By similarity). {ECO:0000250|UniProtKB:P46062, ECO:0000269|PubMed:9346962}. |
Q96JY6 | PDLIM2 | S197 | ochoa | PDZ and LIM domain protein 2 (PDZ-LIM protein mystique) | Probable adapter protein located at the actin cytoskeleton that promotes cell attachment. Necessary for the migratory capacity of epithelial cells. Overexpression enhances cell adhesion to collagen and fibronectin and suppresses anchorage independent growth. May contribute to tumor cell migratory capacity. {ECO:0000269|PubMed:15659642}. |
Q96KS0 | EGLN2 | S234 | psp | Prolyl hydroxylase EGLN2 (EC 1.14.11.-) (Egl nine homolog 2) (EC 1.14.11.29) (Estrogen-induced tag 6) (EIT-6) (HPH-3) (Hypoxia-inducible factor prolyl hydroxylase 1) (HIF-PH1) (HIF-prolyl hydroxylase 1) (HPH-1) (Prolyl hydroxylase domain-containing protein 1) (PHD1) | Prolyl hydroxylase that mediates hydroxylation of proline residues in target proteins, such as ATF4, IKBKB, CEP192 and HIF1A (PubMed:11595184, PubMed:12039559, PubMed:15925519, PubMed:16509823, PubMed:17114296, PubMed:23932902). Target proteins are preferentially recognized via a LXXLAP motif (PubMed:11595184, PubMed:12039559, PubMed:15925519). Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins (PubMed:11595184, PubMed:12039559, PubMed:12181324, PubMed:15925519, PubMed:19339211). Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A (PubMed:11595184, PubMed:12039559, PubMed:12181324, PubMed:15925519). Also hydroxylates HIF2A (PubMed:11595184, PubMed:12039559, PubMed:15925519). Has a preference for the CODD site for both HIF1A and HIF2A (PubMed:11595184, PubMed:12039559, PubMed:15925519). Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex (PubMed:11595184, PubMed:12039559, PubMed:15925519). Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes (PubMed:11595184, PubMed:12039559, PubMed:15925519). EGLN2 is involved in regulating hypoxia tolerance and apoptosis in cardiac and skeletal muscle (PubMed:11595184, PubMed:12039559, PubMed:15925519). Also regulates susceptibility to normoxic oxidative neuronal death (PubMed:11595184, PubMed:12039559, PubMed:15925519). Links oxygen sensing to cell cycle and primary cilia formation by hydroxylating the critical centrosome component CEP192 which promotes its ubiquitination and subsequent proteasomal degradation (PubMed:23932902). Hydroxylates IKBKB, mediating NF-kappa-B activation in hypoxic conditions (PubMed:17114296). Also mediates hydroxylation of ATF4, leading to decreased protein stability of ATF4 (By similarity). {ECO:0000250|UniProtKB:Q91YE2, ECO:0000269|PubMed:11595184, ECO:0000269|PubMed:12039559, ECO:0000269|PubMed:12181324, ECO:0000269|PubMed:15925519, ECO:0000269|PubMed:16509823, ECO:0000269|PubMed:17114296, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:23932902}. |
Q96PM9 | ZNF385A | S153 | ochoa | Zinc finger protein 385A (Hematopoietic zinc finger protein) (Retinal zinc finger protein) | RNA-binding protein that affects the localization and the translation of a subset of mRNA. May play a role in adipogenesis through binding to the 3'-UTR of CEBPA mRNA and regulation of its translation. Targets ITPR1 mRNA to dendrites in Purkinje cells, and may regulate its activity-dependent translation. With ELAVL1, binds the 3'-UTR of p53/TP53 mRNAs to control their nuclear export induced by CDKN2A. Hence, may regulate p53/TP53 expression and mediate in part the CDKN2A anti-proliferative activity. May also bind CCNB1 mRNA. Alternatively, may also regulate p53/TP53 activity through direct protein-protein interaction. Interacts with p53/TP53 and promotes cell-cycle arrest over apoptosis enhancing preferentially the DNA binding and transactivation of p53/TP53 on cell-cycle arrest target genes over proapoptotic target genes. May also regulate the ubiquitination and stability of CDKN1A promoting DNA damage-induced cell cycle arrest. Also plays a role in megakaryocytes differentiation. {ECO:0000269|PubMed:17719541}. |
Q96S66 | CLCC1 | S438 | ochoa | Chloride channel CLIC-like protein 1 (ER anion channel 1) (ERAC1) (Mid-1-related chloride channel protein) | Anion-selective channel with Ca(2+)-dependent and voltage-independent gating. Permeable to small monovalent anions with selectivity for bromide > chloride > nitrate > fluoride (By similarity). Operates in the endoplasmic reticulum (ER) membrane where it mediates chloride efflux to compensate for the loss of positive charges from the ER lumen upon Ca(2+) release. Contributes to the maintenance of ER Ca(2+) pools and activation of unfolded protein response to prevent accumulation of misfolded proteins in the ER lumen. Particularly involved in ER homeostasis mechanisms underlying motor neurons and retinal photoreceptors survival (By similarity) (PubMed:25698737, PubMed:30157172, PubMed:37142673). {ECO:0000250|UniProtKB:Q99LI2, ECO:0000269|PubMed:25698737, ECO:0000269|PubMed:30157172, ECO:0000269|PubMed:37142673}. |
Q99490 | AGAP2 | S818 | ochoa | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 (AGAP-2) (Centaurin-gamma-1) (Cnt-g1) (GTP-binding and GTPase-activating protein 2) (GGAP2) (Phosphatidylinositol 3-kinase enhancer) (PIKE) | GTPase-activating protein (GAP) for ARF1 and ARF5, which also shows strong GTPase activity. Isoform 1 participates in the prevention of neuronal apoptosis by enhancing PI3 kinase activity. It aids the coupling of metabotropic glutamate receptor 1 (GRM1) to cytoplasmic PI3 kinase by interacting with Homer scaffolding proteins, and also seems to mediate anti-apoptotic effects of NGF by activating nuclear PI3 kinase. Isoform 2 does not stimulate PI3 kinase but may protect cells from apoptosis by stimulating Akt. It also regulates the adapter protein 1 (AP-1)-dependent trafficking of proteins in the endosomal system. It seems to be oncogenic. It is overexpressed in cancer cells, prevents apoptosis and promotes cancer cell invasion. {ECO:0000269|PubMed:12640130, ECO:0000269|PubMed:14761976, ECO:0000269|PubMed:15118108, ECO:0000269|PubMed:16079295}. |
Q9BQ65 | USB1 | S36 | ochoa | U6 snRNA phosphodiesterase 1 (hUsb1) (3'-5' RNA exonuclease USB1) (EC 4.6.1.-) (Mutated in poikiloderma with neutropenia protein 1) (Mutated in PN protein 1) (hMpn1) | 3'-5' RNA exonuclease that trims the 3' end of oligo(U) and oligo(A) tracts of the pre-U6 small nuclear RNA (snRNA) molecule, leading to the formation of a mature U6 snRNA 3' end-terminated with a 2',3'-cyclic phosphate (PubMed:22899009, PubMed:23022480, PubMed:23190533, PubMed:26213367, PubMed:28887445, PubMed:30215753, PubMed:31832688). Participates in the U6 snRNA 3' end processing that prevents U6 snRNA degradation (PubMed:22899009, PubMed:23022480, PubMed:23190533, PubMed:26213367, PubMed:28887445, PubMed:30215753, PubMed:31832688). In addition also removes uridines from the 3' end of U6atac snRNA and possibly the vault RNA VTRNA1-1 (PubMed:26213367). {ECO:0000269|PubMed:22899009, ECO:0000269|PubMed:23022480, ECO:0000269|PubMed:23190533, ECO:0000269|PubMed:26213367, ECO:0000269|PubMed:28887445, ECO:0000269|PubMed:30215753, ECO:0000269|PubMed:31832688}. |
Q9BQQ3 | GORASP1 | S274 | psp | Golgi reassembly-stacking protein 1 (Golgi peripheral membrane protein p65) (Golgi phosphoprotein 5) (GOLPH5) (Golgi reassembly-stacking protein of 65 kDa) (GRASP65) | Key structural protein of the Golgi apparatus (PubMed:33301566). The membrane cisternae of the Golgi apparatus adhere to each other to form stacks, which are aligned side by side to form the Golgi ribbon (PubMed:33301566). Acting in concert with GORASP2/GRASP55, is required for the formation and maintenance of the Golgi ribbon, and may be dispensable for the formation of stacks (PubMed:33301566). However, other studies suggest that GORASP1 plays an important role in assembly and membrane stacking of the cisternae, and in the reassembly of Golgi stacks after breakdown during mitosis (By similarity). Caspase-mediated cleavage of GORASP1 is required for fragmentation of the Golgi during apoptosis (By similarity). Also mediates, via its interaction with GOLGA2/GM130, the docking of transport vesicles with the Golgi membranes (PubMed:16489344). Mediates ER stress-induced unconventional (ER/Golgi-independent) trafficking of core-glycosylated CFTR to cell membrane (PubMed:21884936). {ECO:0000250|UniProtKB:O35254, ECO:0000269|PubMed:16489344, ECO:0000269|PubMed:21884936, ECO:0000269|PubMed:33301566}. |
Q9BRD0 | BUD13 | S126 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S188 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BUF5 | TUBB6 | S278 | ochoa | Tubulin beta-6 chain (Tubulin beta class V) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. {ECO:0000250|UniProtKB:P02557}. |
Q9BVA1 | TUBB2B | S278 | ochoa | Tubulin beta-2B chain | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers (PubMed:23001566, PubMed:26732629, PubMed:28013290). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. Plays a critical role in proper axon guidance in both central and peripheral axon tracts (PubMed:23001566). Implicated in neuronal migration (PubMed:19465910). {ECO:0000269|PubMed:19465910, ECO:0000269|PubMed:23001566, ECO:0000269|PubMed:26732629, ECO:0000269|PubMed:28013290}. |
Q9C0D5 | TANC1 | S1503 | ochoa | Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1) | May be a scaffold component in the postsynaptic density. {ECO:0000250}. |
Q9H211 | CDT1 | S394 | ochoa|psp | DNA replication factor Cdt1 (Double parked homolog) (DUP) | Required for both DNA replication and mitosis (PubMed:11125146, PubMed:14993212, PubMed:21856198, PubMed:22581055, PubMed:26842564). DNA replication licensing factor, required for pre-replication complex assembly. Cooperates with CDC6 and the origin recognition complex (ORC) during G1 phase of the cell cycle to promote the loading of the mini-chromosome maintenance (MCM) complex onto DNA to generate pre-replication complexes (pre-RC) (PubMed:14672932). Required also for mitosis by promoting stable kinetochore-microtubule attachments (PubMed:22581055). Potential oncogene (By similarity). {ECO:0000250|UniProtKB:Q8R4E9, ECO:0000269|PubMed:11125146, ECO:0000269|PubMed:14672932, ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22581055, ECO:0000269|PubMed:26842564}. |
Q9H4L4 | SENP3 | S54 | ochoa | Sentrin-specific protease 3 (EC 3.4.22.-) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3) | Protease that releases SUMO2 and SUMO3 monomers from sumoylated substrates, but has only weak activity against SUMO1 conjugates (PubMed:16608850, PubMed:32832608, PubMed:36050397). Deconjugates SUMO2 from MEF2D, which increases its transcriptional activation capability (PubMed:15743823). Deconjugates SUMO2 and SUMO3 from CDCA8 (PubMed:18946085). Redox sensor that, when redistributed into nucleoplasm, can act as an effector to enhance HIF1A transcriptional activity by desumoylating EP300 (PubMed:19680224). Required for rRNA processing through deconjugation of SUMO2 and SUMO3 from nucleophosmin, NPM1 (PubMed:19015314). Plays a role in the regulation of sumoylation status of ZNF148 (PubMed:18259216). Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Deconjugates SUMO2 from KAT5 (PubMed:32832608). Catalyzes desumoylation of MRE11 (PubMed:36050397). {ECO:0000269|PubMed:15743823, ECO:0000269|PubMed:16608850, ECO:0000269|PubMed:18259216, ECO:0000269|PubMed:18946085, ECO:0000269|PubMed:19015314, ECO:0000269|PubMed:19680224, ECO:0000269|PubMed:22872859, ECO:0000269|PubMed:32832608, ECO:0000269|PubMed:36050397}. |
Q9H5J0 | ZBTB3 | S549 | ochoa | Zinc finger and BTB domain-containing protein 3 | May be involved in transcriptional regulation. |
Q9H6F5 | CCDC86 | S160 | ochoa | Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain) | Required for proper chromosome segregation during mitosis and error-free mitotic progression. {ECO:0000269|PubMed:36695333}. |
Q9H7S9 | ZNF703 | S78 | ochoa | Zinc finger protein 703 (Zinc finger elbow-related proline domain protein 1) | Transcriptional corepressor which does not bind directly to DNA and may regulate transcription through recruitment of histone deacetylases to gene promoters. Regulates cell adhesion, migration and proliferation. May be required for segmental gene expression during hindbrain development. {ECO:0000269|PubMed:21328542, ECO:0000269|PubMed:21337521}. |
Q9H8M5 | CNNM2 | S743 | ochoa | Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2) | Divalent metal cation transporter. Mediates transport of divalent metal cations in an order of Mg(2+) > Co(2+) > Mn(2+) > Sr(2+) > Ba(2+) > Cu(2+) > Fe(2+) (By similarity). {ECO:0000250|UniProtKB:Q3TWN3}. |
Q9H9L7 | AKIRIN1 | S22 | ochoa | Akirin-1 | Molecular adapter that acts as a bridge between proteins, and which is involved skeletal muscle development (By similarity). Functions as a signal transducer for MSTN during skeletal muscle regeneration and myogenesis (By similarity). May regulate chemotaxis of both macrophages and myoblasts by reorganising actin cytoskeleton, leading to more efficient lamellipodia formation via a PI3 kinase dependent pathway (By similarity). In contrast to AKIRIN2, not involved in nuclear import of proteasomes (PubMed:34711951). {ECO:0000250|UniProtKB:Q99LF1, ECO:0000269|PubMed:34711951}. |
Q9HCE9 | ANO8 | S641 | ochoa | Anoctamin-8 (Transmembrane protein 16H) | Does not exhibit calcium-activated chloride channel (CaCC) activity. |
Q9NSC5 | HOMER3 | S141 | ochoa | Homer protein homolog 3 (Homer-3) | Postsynaptic density scaffolding protein. Binds and cross-links cytoplasmic regions of GRM1, GRM5, ITPR1, DNM3, RYR1, RYR2, SHANK1 and SHANK3. By physically linking GRM1 and GRM5 with ER-associated ITPR1 receptors, it aids the coupling of surface receptors to intracellular calcium release. Isoforms can be differently regulated and may play an important role in maintaining the plasticity at glutamatergic synapses. Negatively regulates T cell activation by inhibiting the calcineurin-NFAT pathway. Acts by competing with calcineurin/PPP3CA for NFAT protein binding, hence preventing NFAT activation by PPP3CA (PubMed:18218901). {ECO:0000269|PubMed:18218901}. |
Q9NYV4 | CDK12 | S268 | ochoa | Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) | Cyclin-dependent kinase that phosphorylates the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A), thereby acting as a key regulator of transcription elongation. Regulates the expression of genes involved in DNA repair and is required for the maintenance of genomic stability. Preferentially phosphorylates 'Ser-5' in CTD repeats that are already phosphorylated at 'Ser-7', but can also phosphorylate 'Ser-2'. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogen inhibitors. {ECO:0000269|PubMed:11683387, ECO:0000269|PubMed:19651820, ECO:0000269|PubMed:20952539, ECO:0000269|PubMed:22012619, ECO:0000269|PubMed:24662513}. |
Q9P1Y6 | PHRF1 | S1229 | ochoa | PHD and RING finger domain-containing protein 1 | None |
Q9P242 | NYAP2 | S469 | ochoa | Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2 | Activates PI3K and concomitantly recruits the WAVE1 complex to the close vicinity of PI3K and regulates neuronal morphogenesis. {ECO:0000250}. |
Q9UGJ0 | PRKAG2 | S71 | ochoa | 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) | AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism (PubMed:14722619, PubMed:24563466). In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation (PubMed:14722619, PubMed:24563466). AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators (PubMed:14722619, PubMed:24563466). Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin (PubMed:14722619, PubMed:24563466). Gamma non-catalytic subunit mediates binding to AMP, ADP and ATP, leading to activate or inhibit AMPK: AMP-binding results in allosteric activation of alpha catalytic subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and preventing dephosphorylation of catalytic subunits (PubMed:14722619, PubMed:24563466). ADP also stimulates phosphorylation, without stimulating already phosphorylated catalytic subunit (PubMed:14722619, PubMed:24563466). ATP promotes dephosphorylation of catalytic subunit, rendering the AMPK enzyme inactive (PubMed:14722619, PubMed:24563466). {ECO:0000269|PubMed:14722619, ECO:0000269|PubMed:24563466}. |
Q9UGP4 | LIMD1 | S424 | ochoa|psp | LIM domain-containing protein 1 | Adapter or scaffold protein which participates in the assembly of numerous protein complexes and is involved in several cellular processes such as cell fate determination, cytoskeletal organization, repression of gene transcription, cell-cell adhesion, cell differentiation, proliferation and migration. Positively regulates microRNA (miRNA)-mediated gene silencing and is essential for P-body formation and integrity. Acts as a hypoxic regulator by bridging an association between the prolyl hydroxylases and VHL enabling efficient degradation of HIF1A. Acts as a transcriptional corepressor for SNAI1- and SNAI2/SLUG-dependent repression of E-cadherin transcription. Negatively regulates the Hippo signaling pathway and antagonizes phosphorylation of YAP1. Inhibits E2F-mediated transcription, and suppresses the expression of the majority of genes with E2F1-responsive elements. Regulates osteoblast development, function, differentiation and stress osteoclastogenesis. Enhances the ability of TRAF6 to activate adapter protein complex 1 (AP-1) and negatively regulates the canonical Wnt receptor signaling pathway in osteoblasts. May act as a tumor suppressor by inhibiting cell proliferation. {ECO:0000269|PubMed:15542589, ECO:0000269|PubMed:20303269, ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22286099}. |
Q9UIS9 | MBD1 | S399 | ochoa | Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1) | Transcriptional repressor that binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. Binding is abolished by the presence of 7-mG that is produced by DNA damage by methylmethanesulfonate (MMS). Acts as transcriptional repressor and plays a role in gene silencing by recruiting ATF7IP, which in turn recruits factors such as the histone methyltransferase SETDB1. Probably forms a complex with SETDB1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Isoform 1 and isoform 2 can also repress transcription from unmethylated promoters. {ECO:0000269|PubMed:10454587, ECO:0000269|PubMed:10648624, ECO:0000269|PubMed:12665582, ECO:0000269|PubMed:12697822, ECO:0000269|PubMed:12711603, ECO:0000269|PubMed:14555760, ECO:0000269|PubMed:14610093, ECO:0000269|PubMed:9207790, ECO:0000269|PubMed:9774669}. |
Q9UK80 | USP21 | S93 | ochoa|psp | Ubiquitin carboxyl-terminal hydrolase 21 (EC 3.4.19.12) (Deubiquitinating enzyme 21) (Ubiquitin thioesterase 21) (Ubiquitin-specific-processing protease 21) | Deubiquitinates histone H2A, a specific tag for epigenetic transcriptional repression, thereby acting as a coactivator (By similarity). Deubiquitination of histone H2A releaves the repression of di- and trimethylation of histone H3 at 'Lys-4', resulting in regulation of transcriptional initiation (By similarity). Regulates gene expression via histone H2A deubiquitination (By similarity). Deubiquitinates BAZ2A/TIP5 leading to its stabilization (PubMed:26100909). Also capable of removing NEDD8 from NEDD8 conjugates but has no effect on Sentrin-1 conjugates (PubMed:10799498). Also acts as a negative regulator of the ribosome quality control (RQC) by mediating deubiquitination of 40S ribosomal proteins RPS10/eS10 and RPS20/uS10, thereby antagonizing ZNF598-mediated 40S ubiquitination (PubMed:32011234). {ECO:0000250|UniProtKB:Q9QZL6, ECO:0000269|PubMed:10799498, ECO:0000269|PubMed:26100909, ECO:0000269|PubMed:32011234}. |
Q9ULD5 | ZNF777 | S623 | ochoa | Zinc finger protein 777 | May be involved in transcriptional repression (PubMed:31856708). Inhibits cell proliferation through CDKN1A/p21 induction by down-regulation of NIBAN1/FAM129A at low cell density (PubMed:25560148). {ECO:0000269|PubMed:25560148, ECO:0000269|PubMed:31856708}. |
Q9ULX9 | MAFF | S146 | ochoa | Transcription factor MafF (U-Maf) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog F) | Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves (PubMed:8932385). However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins, such as NFE2L1/NRF1, and recruiting them to specific DNA-binding sites. Interacts with the upstream promoter region of the oxytocin receptor gene (PubMed:16549056, PubMed:8932385). May be a transcriptional enhancer in the up-regulation of the oxytocin receptor gene at parturition (PubMed:10527846). {ECO:0000269|PubMed:10527846, ECO:0000269|PubMed:16549056, ECO:0000269|PubMed:8932385}. |
Q9UMN6 | KMT2B | S1890 | ochoa | Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.364) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism. Part of chromatin remodeling machinery predominantly forms H3K4me1 and H3K4me2 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17707229, PubMed:25561738). Likely plays a redundant role with KMT2C in enriching H3K4me1 marks on primed and active enhancer elements (PubMed:24081332). Plays a central role in beta-globin locus transcription regulation by being recruited by NFE2 (PubMed:17707229). Plays an important role in controlling bulk H3K4me during oocyte growth and preimplantation development (By similarity). Required during the transcriptionally active period of oocyte growth for the establishment and/or maintenance of bulk H3K4 trimethylation (H3K4me3), global transcriptional silencing that preceeds resumption of meiosis, oocyte survival and normal zygotic genome activation (By similarity). {ECO:0000250|UniProtKB:O08550, ECO:0000269|PubMed:17707229, ECO:0000269|PubMed:24081332, ECO:0000269|PubMed:25561738}. |
Q9UPP1 | PHF8 | S880 | ochoa|psp | Histone lysine demethylase PHF8 (EC 1.14.11.27) (EC 1.14.11.65) (PHD finger protein 8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8) | Histone lysine demethylase with selectivity for the di- and monomethyl states that plays a key role cell cycle progression, rDNA transcription and brain development. Demethylates mono- and dimethylated histone H3 'Lys-9' residue (H3K9Me1 and H3K9Me2), dimethylated H3 'Lys-27' (H3K27Me2) and monomethylated histone H4 'Lys-20' residue (H4K20Me1). Acts as a transcription activator as H3K9Me1, H3K9Me2, H3K27Me2 and H4K20Me1 are epigenetic repressive marks. Involved in cell cycle progression by being required to control G1-S transition. Acts as a coactivator of rDNA transcription, by activating polymerase I (pol I) mediated transcription of rRNA genes. Required for brain development, probably by regulating expression of neuron-specific genes. Only has activity toward H4K20Me1 when nucleosome is used as a substrate and when not histone octamer is used as substrate. May also have weak activity toward dimethylated H3 'Lys-36' (H3K36Me2), however, the relevance of this result remains unsure in vivo. Specifically binds trimethylated 'Lys-4' of histone H3 (H3K4me3), affecting histone demethylase specificity: has weak activity toward H3K9Me2 in absence of H3K4me3, while it has high activity toward H3K9me2 when binding H3K4me3. Positively modulates transcription of histone demethylase KDM5C, acting synergistically with transcription factor ARX; synergy may be related to enrichment of histone H3K4me3 in regulatory elements. {ECO:0000269|PubMed:19843542, ECO:0000269|PubMed:20023638, ECO:0000269|PubMed:20101266, ECO:0000269|PubMed:20208542, ECO:0000269|PubMed:20346720, ECO:0000269|PubMed:20421419, ECO:0000269|PubMed:20531378, ECO:0000269|PubMed:20548336, ECO:0000269|PubMed:20622853, ECO:0000269|PubMed:20622854, ECO:0000269|PubMed:31691806}. |
Q9UQ35 | SRRM2 | S1064 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9Y2K7 | KDM2A | S731 | ochoa | Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A) | Histone demethylase that specifically demethylates 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis. Regulates circadian gene expression by repressing the transcriptional activator activity of CLOCK-BMAL1 heterodimer and RORA in a catalytically-independent manner (PubMed:26037310). {ECO:0000269|PubMed:16362057, ECO:0000269|PubMed:19001877, ECO:0000269|PubMed:26037310, ECO:0000269|PubMed:28262558}. |
Q9Y2X7 | GIT1 | S498 | ochoa|psp | ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1) | GTPase-activating protein for ADP ribosylation factor family members, including ARF1. Multidomain scaffold protein that interacts with numerous proteins and therefore participates in many cellular functions, including receptor internalization, focal adhesion remodeling, and signaling by both G protein-coupled receptors and tyrosine kinase receptors (By similarity). Through PAK1 activation, positively regulates microtubule nucleation during interphase (PubMed:27012601). Plays a role in the regulation of cytokinesis; for this function, may act in a pathway also involving ENTR1 and PTPN13 (PubMed:23108400). May promote cell motility both by regulating focal complex dynamics and by local activation of RAC1 (PubMed:10938112, PubMed:11896197). May act as scaffold for MAPK1/3 signal transduction in focal adhesions. Recruits MAPK1/3/ERK1/2 to focal adhesions after EGF stimulation via a Src-dependent pathway, hence stimulating cell migration (PubMed:15923189). Plays a role in brain development and function. Involved in the regulation of spine density and synaptic plasticity that is required for processes involved in learning (By similarity). Plays an important role in dendritic spine morphogenesis and synapse formation (PubMed:12695502, PubMed:15800193). In hippocampal neurons, recruits guanine nucleotide exchange factors (GEFs), such as ARHGEF7/beta-PIX, to the synaptic membrane. These in turn locally activate RAC1, which is an essential step for spine morphogenesis and synapse formation (PubMed:12695502). May contribute to the organization of presynaptic active zones through oligomerization and formation of a Piccolo/PCLO-based protein network, which includes ARHGEF7/beta-PIX and FAK1 (By similarity). In neurons, through its interaction with liprin-alpha family members, may be required for AMPA receptor (GRIA2/3) proper targeting to the cell membrane (By similarity). In complex with GABA(A) receptors and ARHGEF7, plays a crucial role in regulating GABA(A) receptor synaptic stability, maintaining GPHN/gephyrin scaffolds and hence GABAergic inhibitory synaptic transmission, by locally coordinating RAC1 and PAK1 downstream effector activity, leading to F-actin stabilization (PubMed:25284783). May also be important for RAC1 downstream signaling pathway through PAK3 and regulation of neuronal inhibitory transmission at presynaptic input (By similarity). Required for successful bone regeneration during fracture healing (By similarity). The function in intramembranous ossification may, at least partly, exerted by macrophages in which GIT1 is a key negative regulator of redox homeostasis, IL1B production, and glycolysis, acting through the ERK1/2/NRF2/NFE2L2 axis (By similarity). May play a role in angiogenesis during fracture healing (By similarity). In this process, may regulate activation of the canonical NF-kappa-B signal in bone mesenchymal stem cells by enhancing the interaction between NEMO and 'Lys-63'-ubiquitinated RIPK1/RIP1, eventually leading to enhanced production of VEGFA and others angiogenic factors (PubMed:31502302). Essential for VEGF signaling through the activation of phospholipase C-gamma and ERK1/2, hence may control endothelial cell proliferation and angiogenesis (PubMed:19273721). {ECO:0000250|UniProtKB:Q68FF6, ECO:0000250|UniProtKB:Q9Z272, ECO:0000269|PubMed:10938112, ECO:0000269|PubMed:11896197, ECO:0000269|PubMed:12695502, ECO:0000269|PubMed:15800193, ECO:0000269|PubMed:15923189, ECO:0000269|PubMed:19273721, ECO:0000269|PubMed:23108400, ECO:0000269|PubMed:25284783, ECO:0000269|PubMed:27012601, ECO:0000269|PubMed:31502302}. |
Q9Y2X7 | GIT1 | S514 | ochoa | ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1) | GTPase-activating protein for ADP ribosylation factor family members, including ARF1. Multidomain scaffold protein that interacts with numerous proteins and therefore participates in many cellular functions, including receptor internalization, focal adhesion remodeling, and signaling by both G protein-coupled receptors and tyrosine kinase receptors (By similarity). Through PAK1 activation, positively regulates microtubule nucleation during interphase (PubMed:27012601). Plays a role in the regulation of cytokinesis; for this function, may act in a pathway also involving ENTR1 and PTPN13 (PubMed:23108400). May promote cell motility both by regulating focal complex dynamics and by local activation of RAC1 (PubMed:10938112, PubMed:11896197). May act as scaffold for MAPK1/3 signal transduction in focal adhesions. Recruits MAPK1/3/ERK1/2 to focal adhesions after EGF stimulation via a Src-dependent pathway, hence stimulating cell migration (PubMed:15923189). Plays a role in brain development and function. Involved in the regulation of spine density and synaptic plasticity that is required for processes involved in learning (By similarity). Plays an important role in dendritic spine morphogenesis and synapse formation (PubMed:12695502, PubMed:15800193). In hippocampal neurons, recruits guanine nucleotide exchange factors (GEFs), such as ARHGEF7/beta-PIX, to the synaptic membrane. These in turn locally activate RAC1, which is an essential step for spine morphogenesis and synapse formation (PubMed:12695502). May contribute to the organization of presynaptic active zones through oligomerization and formation of a Piccolo/PCLO-based protein network, which includes ARHGEF7/beta-PIX and FAK1 (By similarity). In neurons, through its interaction with liprin-alpha family members, may be required for AMPA receptor (GRIA2/3) proper targeting to the cell membrane (By similarity). In complex with GABA(A) receptors and ARHGEF7, plays a crucial role in regulating GABA(A) receptor synaptic stability, maintaining GPHN/gephyrin scaffolds and hence GABAergic inhibitory synaptic transmission, by locally coordinating RAC1 and PAK1 downstream effector activity, leading to F-actin stabilization (PubMed:25284783). May also be important for RAC1 downstream signaling pathway through PAK3 and regulation of neuronal inhibitory transmission at presynaptic input (By similarity). Required for successful bone regeneration during fracture healing (By similarity). The function in intramembranous ossification may, at least partly, exerted by macrophages in which GIT1 is a key negative regulator of redox homeostasis, IL1B production, and glycolysis, acting through the ERK1/2/NRF2/NFE2L2 axis (By similarity). May play a role in angiogenesis during fracture healing (By similarity). In this process, may regulate activation of the canonical NF-kappa-B signal in bone mesenchymal stem cells by enhancing the interaction between NEMO and 'Lys-63'-ubiquitinated RIPK1/RIP1, eventually leading to enhanced production of VEGFA and others angiogenic factors (PubMed:31502302). Essential for VEGF signaling through the activation of phospholipase C-gamma and ERK1/2, hence may control endothelial cell proliferation and angiogenesis (PubMed:19273721). {ECO:0000250|UniProtKB:Q68FF6, ECO:0000250|UniProtKB:Q9Z272, ECO:0000269|PubMed:10938112, ECO:0000269|PubMed:11896197, ECO:0000269|PubMed:12695502, ECO:0000269|PubMed:15800193, ECO:0000269|PubMed:15923189, ECO:0000269|PubMed:19273721, ECO:0000269|PubMed:23108400, ECO:0000269|PubMed:25284783, ECO:0000269|PubMed:27012601, ECO:0000269|PubMed:31502302}. |
Q9Y3S1 | WNK2 | S560 | ochoa | Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) | Serine/threonine-protein kinase component of the WNK2-SPAK/OSR1 kinase cascade, which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation (PubMed:17667937, PubMed:18593598, PubMed:21733846). The WNK2-SPAK/OSR1 kinase cascade is composed of WNK2, which mediates phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK (By similarity). Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters, regulating their activity (By similarity). Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively (PubMed:21733846). Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5 (PubMed:21733846). Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression (PubMed:17667937, PubMed:18593598). Affects MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this modulation depends on phosphorylation of MAP2K1 by PAK1 (PubMed:17667937, PubMed:18593598). WNK2 acts by interfering with the activity of PAK1 by controlling the balance of the activity of upstream regulators of PAK1 activity, RHOA and RAC1, which display reciprocal activity (PubMed:17667937, PubMed:18593598). {ECO:0000250|UniProtKB:Q9H4A3, ECO:0000269|PubMed:17667937, ECO:0000269|PubMed:18593598, ECO:0000269|PubMed:21733846}. |
Q9Y4Z2 | NEUROG3 | S174 | psp | Neurogenin-3 (NGN-3) (Class A basic helix-loop-helix protein 7) (bHLHa7) (Protein atonal homolog 5) | Acts as a transcriptional regulator. Together with NKX2-2, initiates transcriptional activation of NEUROD1. Involved in neurogenesis. Also required for the specification of a common precursor of the 4 pancreatic endocrine cell types (By similarity). {ECO:0000250}. |
Q9Y6I3 | EPN1 | S447 | ochoa | Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1) | Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). Modifies membrane curvature and facilitates the formation of clathrin-coated invaginations (By similarity). Regulates receptor-mediated endocytosis (PubMed:10393179, PubMed:10557078). {ECO:0000250|UniProtKB:O88339, ECO:0000269|PubMed:10393179, ECO:0000269|PubMed:10557078}. |
Q9Y6X9 | MORC2 | S696 | ochoa | ATPase MORC2 (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2) (Zinc finger CW-type coiled-coil domain protein 1) | Essential for epigenetic silencing by the HUSH (human silencing hub) complex. Recruited by HUSH to target site in heterochromatin, the ATPase activity and homodimerization are critical for HUSH-mediated silencing (PubMed:28581500, PubMed:29440755, PubMed:32693025). Represses germ cell-related genes and L1 retrotransposons in collaboration with SETDB1 and the HUSH complex, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression (PubMed:29211708). During DNA damage response, regulates chromatin remodeling through ATP hydrolysis. Upon DNA damage, is phosphorylated by PAK1, both colocalize to chromatin and induce H2AX expression. ATPase activity is required and dependent of phosphorylation by PAK1 and presence of DNA (PubMed:23260667). Recruits histone deacetylases, such as HDAC4, to promoter regions, causing local histone H3 deacetylation and transcriptional repression of genes such as CA9 (PubMed:20110259, PubMed:20225202). Exhibits a cytosolic function in lipogenesis, adipogenic differentiation, and lipid homeostasis by increasing the activity of ACLY, possibly preventing its dephosphorylation (PubMed:24286864). {ECO:0000269|PubMed:20110259, ECO:0000269|PubMed:20225202, ECO:0000269|PubMed:23260667, ECO:0000269|PubMed:24286864, ECO:0000269|PubMed:28581500, ECO:0000269|PubMed:29211708, ECO:0000269|PubMed:29440755, ECO:0000269|PubMed:32693025}. |
P05187 | ALPP | S438 | Sugiyama | Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1) | Alkaline phosphatase that can hydrolyze various phosphate compounds. {ECO:0000269|PubMed:1939159, ECO:0000269|PubMed:25775211}. |
P10696 | ALPG | S435 | Sugiyama | Alkaline phosphatase, germ cell type (EC 3.1.3.1) (ALP-1) (Alkaline phosphatase Nagao isozyme) (Alkaline phosphatase, placental-like) (Germ cell alkaline phosphatase) (GCAP) (Placental alkaline phosphatase-like) (PLAP-like) | Alkaline phosphatase that can hydrolyze various phosphate compounds. {ECO:0000269|PubMed:1939159}. |
Q9NP71 | MLXIPL | S556 | SIGNOR | Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) | Binds DNA as a heterodimer with MLX/TCFL4 and activates transcription. Binds to the canonical E box sequence 5'-CACGTG-3'. Plays a role in transcriptional activation of glycolytic target genes. Involved in glucose-responsive gene regulation (By similarity). Regulates transcription in response to changes in cellular carbohydrate abundance such as occurs during fasting to feeding metabolic transition. Refeeding stimulates MLXIPL/ChREBP transcription factor, leading to increased BCKDK to PPM1K expression ratio, phosphorylation and activation of ACLY that ultimately results in the generation of malonyl-CoA and oxaloacetate immediate substrates of de novo lipogenesis and gluconeogenesis, respectively (By similarity). {ECO:0000250|UniProtKB:Q2VPU4, ECO:0000250|UniProtKB:Q9HAP2}. |
P08151 | GLI1 | S569 | GPS6 | Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI) | Acts as a transcriptional activator (PubMed:10806483, PubMed:19706761, PubMed:19878745, PubMed:24076122, PubMed:24217340, PubMed:24311597). Binds to the DNA consensus sequence 5'-GACCACCCA-3' (PubMed:2105456, PubMed:24217340, PubMed:8378770). Regulates the transcription of specific genes during normal development (PubMed:19706761). Plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Mediates SHH signaling (PubMed:19706761, PubMed:28973407). Plays a role in cell proliferation and differentiation via its role in SHH signaling (PubMed:11238441, PubMed:28973407). {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441, ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:2105456, ECO:0000269|PubMed:24076122, ECO:0000269|PubMed:24217340, ECO:0000269|PubMed:24311597, ECO:0000269|PubMed:28973407, ECO:0000269|PubMed:8378770}.; FUNCTION: [Isoform 2]: Acts as a transcriptional activator, but activates a different set of genes than isoform 1. Activates expression of CD24, unlike isoform 1. Mediates SHH signaling. Promotes cancer cell migration. {ECO:0000269|PubMed:19706761}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-9619483 | Activation of AMPK downstream of NMDARs | 3.266796e-10 | 9.486 |
R-HSA-190840 | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 9.077223e-09 | 8.042 |
R-HSA-190872 | Transport of connexons to the plasma membrane | 1.227218e-08 | 7.911 |
R-HSA-438064 | Post NMDA receptor activation events | 2.113477e-07 | 6.675 |
R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III | 4.242868e-07 | 6.372 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 5.105989e-07 | 6.292 |
R-HSA-190861 | Gap junction assembly | 5.907109e-07 | 6.229 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 1.005657e-06 | 5.998 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 8.322648e-07 | 6.080 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 9.136714e-07 | 6.039 |
R-HSA-69278 | Cell Cycle, Mitotic | 1.216128e-06 | 5.915 |
R-HSA-9646399 | Aggrephagy | 1.450862e-06 | 5.838 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 1.674414e-06 | 5.776 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 1.905468e-06 | 5.720 |
R-HSA-190828 | Gap junction trafficking | 2.806650e-06 | 5.552 |
R-HSA-1640170 | Cell Cycle | 3.597685e-06 | 5.444 |
R-HSA-8955332 | Carboxyterminal post-translational modifications of tubulin | 4.038718e-06 | 5.394 |
R-HSA-437239 | Recycling pathway of L1 | 4.038718e-06 | 5.394 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 4.363964e-06 | 5.360 |
R-HSA-157858 | Gap junction trafficking and regulation | 5.087734e-06 | 5.293 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 5.752037e-06 | 5.240 |
R-HSA-9833482 | PKR-mediated signaling | 9.473457e-06 | 5.023 |
R-HSA-389977 | Post-chaperonin tubulin folding pathway | 1.191168e-05 | 4.924 |
R-HSA-983189 | Kinesins | 1.575156e-05 | 4.803 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 1.892847e-05 | 4.723 |
R-HSA-68886 | M Phase | 1.880795e-05 | 4.726 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 1.893023e-05 | 4.723 |
R-HSA-9663891 | Selective autophagy | 1.892847e-05 | 4.723 |
R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 2.411384e-05 | 4.618 |
R-HSA-389960 | Formation of tubulin folding intermediates by CCT/TriC | 2.830647e-05 | 4.548 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 3.179082e-05 | 4.498 |
R-HSA-68877 | Mitotic Prometaphase | 3.875927e-05 | 4.412 |
R-HSA-6807878 | COPI-mediated anterograde transport | 3.768363e-05 | 4.424 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 4.051087e-05 | 4.392 |
R-HSA-2467813 | Separation of Sister Chromatids | 5.469032e-05 | 4.262 |
R-HSA-389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 7.574179e-05 | 4.121 |
R-HSA-210744 | Regulation of gene expression in late stage (branching morphogenesis) pancreatic... | 9.201972e-05 | 4.036 |
R-HSA-68882 | Mitotic Anaphase | 9.968749e-05 | 4.001 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 1.034164e-04 | 3.985 |
R-HSA-69275 | G2/M Transition | 1.436683e-04 | 3.843 |
R-HSA-373760 | L1CAM interactions | 1.433843e-04 | 3.843 |
R-HSA-453274 | Mitotic G2-G2/M phases | 1.552618e-04 | 3.809 |
R-HSA-9022534 | Loss of MECP2 binding ability to 5hmC-DNA | 2.558271e-04 | 3.592 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 2.594968e-04 | 3.586 |
R-HSA-5610787 | Hedgehog 'off' state | 3.230036e-04 | 3.491 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 3.403848e-04 | 3.468 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 3.806804e-04 | 3.419 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 4.422005e-04 | 3.354 |
R-HSA-5620924 | Intraflagellar transport | 5.053938e-04 | 3.296 |
R-HSA-1632852 | Macroautophagy | 5.217750e-04 | 3.283 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 6.383210e-04 | 3.195 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 6.901918e-04 | 3.161 |
R-HSA-5617833 | Cilium Assembly | 7.478183e-04 | 3.126 |
R-HSA-9609690 | HCMV Early Events | 9.104973e-04 | 3.041 |
R-HSA-9612973 | Autophagy | 9.684438e-04 | 3.014 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 1.112036e-03 | 2.954 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 1.124490e-03 | 2.949 |
R-HSA-6804759 | Regulation of TP53 Activity through Association with Co-factors | 1.041959e-03 | 2.982 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 1.034123e-03 | 2.985 |
R-HSA-2132295 | MHC class II antigen presentation | 1.101457e-03 | 2.958 |
R-HSA-9022538 | Loss of MECP2 binding ability to 5mC-DNA | 1.563293e-03 | 2.806 |
R-HSA-1234174 | Cellular response to hypoxia | 1.629030e-03 | 2.788 |
R-HSA-9675151 | Disorders of Developmental Biology | 1.899603e-03 | 2.721 |
R-HSA-5358351 | Signaling by Hedgehog | 2.204897e-03 | 2.657 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 2.003996e-03 | 2.698 |
R-HSA-112315 | Transmission across Chemical Synapses | 2.143784e-03 | 2.669 |
R-HSA-9022927 | MECP2 regulates transcription of genes involved in GABA signaling | 2.234327e-03 | 2.651 |
R-HSA-9022535 | Loss of phosphorylation of MECP2 at T308 | 3.018472e-03 | 2.520 |
R-HSA-5635851 | GLI proteins bind promoters of Hh responsive genes to promote transcription | 3.913099e-03 | 2.407 |
R-HSA-9022537 | Loss of MECP2 binding ability to the NCoR/SMRT complex | 3.913099e-03 | 2.407 |
R-HSA-9609646 | HCMV Infection | 4.166229e-03 | 2.380 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 4.188440e-03 | 2.378 |
R-HSA-112316 | Neuronal System | 4.369200e-03 | 2.360 |
R-HSA-390466 | Chaperonin-mediated protein folding | 5.199847e-03 | 2.284 |
R-HSA-3214842 | HDMs demethylate histones | 5.623168e-03 | 2.250 |
R-HSA-9022707 | MECP2 regulates transcription factors | 6.023506e-03 | 2.220 |
R-HSA-8849473 | PTK6 Expression | 6.023506e-03 | 2.220 |
R-HSA-4411364 | Binding of TCF/LEF:CTNNB1 to target gene promoters | 6.023506e-03 | 2.220 |
R-HSA-8951430 | RUNX3 regulates WNT signaling | 6.023506e-03 | 2.220 |
R-HSA-391251 | Protein folding | 6.669183e-03 | 2.176 |
R-HSA-913531 | Interferon Signaling | 7.174576e-03 | 2.144 |
R-HSA-186712 | Regulation of beta-cell development | 7.660074e-03 | 2.116 |
R-HSA-163680 | AMPK inhibits chREBP transcriptional activation activity | 8.545398e-03 | 2.068 |
R-HSA-2025928 | Calcineurin activates NFAT | 8.545398e-03 | 2.068 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 8.545398e-03 | 2.068 |
R-HSA-9022702 | MECP2 regulates transcription of neuronal ligands | 9.954540e-03 | 2.002 |
R-HSA-5467343 | Deletions in the AMER1 gene destabilize the destruction complex | 1.136176e-02 | 1.945 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 1.172497e-02 | 1.931 |
R-HSA-4839748 | Signaling by AMER1 mutants | 1.305736e-02 | 1.884 |
R-HSA-9697154 | Disorders of Nervous System Development | 1.474642e-02 | 1.831 |
R-HSA-9005895 | Pervasive developmental disorders | 1.474642e-02 | 1.831 |
R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome | 1.474642e-02 | 1.831 |
R-HSA-209543 | p75NTR recruits signalling complexes | 1.474642e-02 | 1.831 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 1.278438e-02 | 1.893 |
R-HSA-4641265 | Repression of WNT target genes | 1.474642e-02 | 1.831 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 1.278438e-02 | 1.893 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 1.276899e-02 | 1.894 |
R-HSA-422475 | Axon guidance | 1.378320e-02 | 1.861 |
R-HSA-2262752 | Cellular responses to stress | 1.591069e-02 | 1.798 |
R-HSA-201556 | Signaling by ALK | 1.623247e-02 | 1.790 |
R-HSA-3214841 | PKMTs methylate histone lysines | 1.814256e-02 | 1.741 |
R-HSA-5607763 | CLEC7A (Dectin-1) induces NFAT activation | 1.838857e-02 | 1.735 |
R-HSA-9673013 | Diseases of Telomere Maintenance | 2.259512e-02 | 1.646 |
R-HSA-9670621 | Defective Inhibition of DNA Recombination at Telomere | 2.259512e-02 | 1.646 |
R-HSA-9006821 | Alternative Lengthening of Telomeres (ALT) | 2.259512e-02 | 1.646 |
R-HSA-9670613 | Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | 2.259512e-02 | 1.646 |
R-HSA-9670615 | Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | 2.259512e-02 | 1.646 |
R-HSA-193639 | p75NTR signals via NF-kB | 2.033729e-02 | 1.692 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 2.191440e-02 | 1.659 |
R-HSA-68875 | Mitotic Prophase | 1.957096e-02 | 1.708 |
R-HSA-9701898 | STAT3 nuclear events downstream of ALK signaling | 2.033729e-02 | 1.692 |
R-HSA-199991 | Membrane Trafficking | 2.218075e-02 | 1.654 |
R-HSA-446353 | Cell-extracellular matrix interactions | 2.033729e-02 | 1.692 |
R-HSA-9675108 | Nervous system development | 2.189835e-02 | 1.660 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 2.459220e-02 | 1.609 |
R-HSA-8953897 | Cellular responses to stimuli | 2.619697e-02 | 1.582 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 2.698221e-02 | 1.569 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 2.766120e-02 | 1.558 |
R-HSA-3247509 | Chromatin modifying enzymes | 2.770679e-02 | 1.557 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 2.822213e-02 | 1.549 |
R-HSA-4839726 | Chromatin organization | 3.603311e-02 | 1.443 |
R-HSA-9671555 | Signaling by PDGFR in disease | 3.871550e-02 | 1.412 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 4.867332e-02 | 1.313 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 4.867332e-02 | 1.313 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 4.862951e-02 | 1.313 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 4.505480e-02 | 1.346 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 4.505480e-02 | 1.346 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 4.071549e-02 | 1.390 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 4.702492e-02 | 1.328 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 4.702492e-02 | 1.328 |
R-HSA-200425 | Carnitine shuttle | 4.401258e-02 | 1.356 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 4.506899e-02 | 1.346 |
R-HSA-9700206 | Signaling by ALK in cancer | 4.863552e-02 | 1.313 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 4.863552e-02 | 1.313 |
R-HSA-9648895 | Response of EIF2AK1 (HRI) to heme deficiency | 4.401258e-02 | 1.356 |
R-HSA-9022699 | MECP2 regulates neuronal receptors and channels | 5.242508e-02 | 1.280 |
R-HSA-9931510 | Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock gene... | 5.242508e-02 | 1.280 |
R-HSA-8854518 | AURKA Activation by TPX2 | 5.378612e-02 | 1.269 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 5.378612e-02 | 1.269 |
R-HSA-9673766 | Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | 5.553919e-02 | 1.255 |
R-HSA-5579006 | Defective GSS causes GSS deficiency | 5.553919e-02 | 1.255 |
R-HSA-9944997 | Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | 5.553919e-02 | 1.255 |
R-HSA-9944971 | Loss of Function of KMT2D in Kabuki Syndrome | 5.553919e-02 | 1.255 |
R-HSA-1280218 | Adaptive Immune System | 6.386691e-02 | 1.195 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 6.458281e-02 | 1.190 |
R-HSA-8866911 | TFAP2 (AP-2) family regulates transcription of cell cycle factors | 6.627324e-02 | 1.179 |
R-HSA-69895 | Transcriptional activation of cell cycle inhibitor p21 | 6.627324e-02 | 1.179 |
R-HSA-69560 | Transcriptional activation of p53 responsive genes | 6.627324e-02 | 1.179 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 6.666714e-02 | 1.176 |
R-HSA-9673768 | Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | 7.688595e-02 | 1.114 |
R-HSA-380287 | Centrosome maturation | 7.058393e-02 | 1.151 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 7.792823e-02 | 1.108 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 7.792823e-02 | 1.108 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 7.792823e-02 | 1.108 |
R-HSA-163358 | PKA-mediated phosphorylation of key metabolic factors | 8.737868e-02 | 1.059 |
R-HSA-4791275 | Signaling by WNT in cancer | 7.076305e-02 | 1.150 |
R-HSA-9937080 | Developmental Lineage of Multipotent Pancreatic Progenitor Cells | 7.076305e-02 | 1.150 |
R-HSA-74713 | IRS activation | 7.688595e-02 | 1.114 |
R-HSA-162582 | Signal Transduction | 7.733623e-02 | 1.112 |
R-HSA-1855204 | Synthesis of IP3 and IP4 in the cytosol | 7.399678e-02 | 1.131 |
R-HSA-8853659 | RET signaling | 8.738340e-02 | 1.059 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 9.083586e-02 | 1.042 |
R-HSA-1980143 | Signaling by NOTCH1 | 7.258053e-02 | 1.139 |
R-HSA-1538133 | G0 and Early G1 | 7.076305e-02 | 1.150 |
R-HSA-69205 | G1/S-Specific Transcription | 8.738340e-02 | 1.059 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 7.076305e-02 | 1.150 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 7.737977e-02 | 1.111 |
R-HSA-109582 | Hemostasis | 7.895042e-02 | 1.103 |
R-HSA-6794362 | Protein-protein interactions at synapses | 9.164935e-02 | 1.038 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 9.388527e-02 | 1.027 |
R-HSA-141424 | Amplification of signal from the kinetochores | 9.388527e-02 | 1.027 |
R-HSA-5653656 | Vesicle-mediated transport | 9.448001e-02 | 1.025 |
R-HSA-210746 | Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | 9.775279e-02 | 1.010 |
R-HSA-8857538 | PTK6 promotes HIF1A stabilization | 9.775279e-02 | 1.010 |
R-HSA-9818749 | Regulation of NFE2L2 gene expression | 9.775279e-02 | 1.010 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 9.881810e-02 | 1.005 |
R-HSA-212165 | Epigenetic regulation of gene expression | 1.001876e-01 | 0.999 |
R-HSA-9031525 | NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | 1.080096e-01 | 0.967 |
R-HSA-9632974 | NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | 1.080096e-01 | 0.967 |
R-HSA-9031528 | NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipo... | 1.080096e-01 | 0.967 |
R-HSA-9726840 | SHOC2 M1731 mutant abolishes MRAS complex function | 1.080096e-01 | 0.967 |
R-HSA-1169092 | Activation of RAS in B cells | 1.181504e-01 | 0.928 |
R-HSA-9660537 | Signaling by MRAS-complex mutants | 1.181504e-01 | 0.928 |
R-HSA-9726842 | Gain-of-function MRAS complexes activate RAF signaling | 1.181504e-01 | 0.928 |
R-HSA-450520 | HuR (ELAVL1) binds and stabilizes mRNA | 1.281766e-01 | 0.892 |
R-HSA-9700645 | ALK mutants bind TKIs | 1.281766e-01 | 0.892 |
R-HSA-163765 | ChREBP activates metabolic gene expression | 1.478901e-01 | 0.830 |
R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | 1.478901e-01 | 0.830 |
R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | 1.478901e-01 | 0.830 |
R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | 1.478901e-01 | 0.830 |
R-HSA-1234158 | Regulation of gene expression by Hypoxia-inducible Factor | 1.575799e-01 | 0.802 |
R-HSA-9623433 | NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | 1.575799e-01 | 0.802 |
R-HSA-5339716 | Signaling by GSK3beta mutants | 1.575799e-01 | 0.802 |
R-HSA-937039 | IRAK1 recruits IKK complex | 1.671602e-01 | 0.777 |
R-HSA-975144 | IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 1.671602e-01 | 0.777 |
R-HSA-4839743 | Signaling by CTNNB1 phospho-site mutants | 1.671602e-01 | 0.777 |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | 1.671602e-01 | 0.777 |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | 1.671602e-01 | 0.777 |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | 1.671602e-01 | 0.777 |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | 1.671602e-01 | 0.777 |
R-HSA-9029558 | NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | 1.766321e-01 | 0.753 |
R-HSA-196299 | Beta-catenin phosphorylation cascade | 1.952556e-01 | 0.709 |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | 2.134601e-01 | 0.671 |
R-HSA-167242 | Abortive elongation of HIV-1 transcript in the absence of Tat | 2.400018e-01 | 0.620 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 2.486495e-01 | 0.604 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 2.571994e-01 | 0.590 |
R-HSA-76071 | RNA Polymerase III Transcription Initiation From Type 3 Promoter | 2.740099e-01 | 0.562 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 2.200422e-01 | 0.657 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 2.368060e-01 | 0.626 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 2.747084e-01 | 0.561 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 2.957544e-01 | 0.529 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 1.350839e-01 | 0.869 |
R-HSA-162658 | Golgi Cisternae Pericentriolar Stack Reorganization | 1.766321e-01 | 0.753 |
R-HSA-9831926 | Nephron development | 2.312551e-01 | 0.636 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 1.296527e-01 | 0.887 |
R-HSA-163767 | PP2A-mediated dephosphorylation of key metabolic factors | 1.080096e-01 | 0.967 |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anapha... | 2.134601e-01 | 0.671 |
R-HSA-3928664 | Ephrin signaling | 2.312551e-01 | 0.636 |
R-HSA-72172 | mRNA Splicing | 1.155143e-01 | 0.937 |
R-HSA-9703465 | Signaling by FLT3 fusion proteins | 3.065041e-01 | 0.514 |
R-HSA-975110 | TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | 2.134601e-01 | 0.671 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 3.065041e-01 | 0.514 |
R-HSA-9027276 | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 1.671602e-01 | 0.777 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 2.656525e-01 | 0.576 |
R-HSA-9927354 | Co-stimulation by ICOS | 1.181504e-01 | 0.928 |
R-HSA-2151209 | Activation of PPARGC1A (PGC-1alpha) by phosphorylation | 1.380894e-01 | 0.860 |
R-HSA-4839744 | Signaling by APC mutants | 1.478901e-01 | 0.830 |
R-HSA-209560 | NF-kB is activated and signals survival | 1.575799e-01 | 0.802 |
R-HSA-4839735 | Signaling by AXIN mutants | 1.575799e-01 | 0.802 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 1.766321e-01 | 0.753 |
R-HSA-9764562 | Regulation of CDH1 mRNA translation by microRNAs | 1.859968e-01 | 0.730 |
R-HSA-181429 | Serotonin Neurotransmitter Release Cycle | 2.312551e-01 | 0.636 |
R-HSA-392451 | G beta:gamma signalling through PI3Kgamma | 2.822727e-01 | 0.549 |
R-HSA-212676 | Dopamine Neurotransmitter Release Cycle | 2.740099e-01 | 0.562 |
R-HSA-5632684 | Hedgehog 'on' state | 2.284132e-01 | 0.641 |
R-HSA-9619229 | Activation of RAC1 downstream of NMDARs | 1.281766e-01 | 0.892 |
R-HSA-428359 | Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RN... | 1.380894e-01 | 0.860 |
R-HSA-426048 | Arachidonate production from DAG | 1.380894e-01 | 0.860 |
R-HSA-210747 | Regulation of gene expression in early pancreatic precursor cells | 1.478901e-01 | 0.830 |
R-HSA-264642 | Acetylcholine Neurotransmitter Release Cycle | 2.571994e-01 | 0.590 |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human ... | 2.571994e-01 | 0.590 |
R-HSA-5357786 | TNFR1-induced proapoptotic signaling | 2.571994e-01 | 0.590 |
R-HSA-181430 | Norepinephrine Neurotransmitter Release Cycle | 2.904420e-01 | 0.537 |
R-HSA-9925561 | Developmental Lineage of Pancreatic Acinar Cells | 2.620640e-01 | 0.582 |
R-HSA-6794361 | Neurexins and neuroligins | 1.506071e-01 | 0.822 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 2.985187e-01 | 0.525 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 2.985187e-01 | 0.525 |
R-HSA-9839394 | TGFBR3 expression | 2.985187e-01 | 0.525 |
R-HSA-210500 | Glutamate Neurotransmitter Release Cycle | 3.065041e-01 | 0.514 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 2.578496e-01 | 0.589 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 1.325074e-01 | 0.878 |
R-HSA-8953854 | Metabolism of RNA | 2.748412e-01 | 0.561 |
R-HSA-9613354 | Lipophagy | 1.281766e-01 | 0.892 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 1.859968e-01 | 0.730 |
R-HSA-9733458 | Induction of Cell-Cell Fusion | 2.044097e-01 | 0.689 |
R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | 2.656525e-01 | 0.576 |
R-HSA-77075 | RNA Pol II CTD phosphorylation and interaction with CE | 2.822727e-01 | 0.549 |
R-HSA-167160 | RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 2.822727e-01 | 0.549 |
R-HSA-6804114 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 2.134601e-01 | 0.671 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 1.438861e-01 | 0.842 |
R-HSA-74160 | Gene expression (Transcription) | 1.436054e-01 | 0.843 |
R-HSA-390666 | Serotonin receptors | 1.380894e-01 | 0.860 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 1.859968e-01 | 0.730 |
R-HSA-388844 | Receptor-type tyrosine-protein phosphatases | 2.044097e-01 | 0.689 |
R-HSA-912526 | Interleukin receptor SHC signaling | 2.822727e-01 | 0.549 |
R-HSA-195721 | Signaling by WNT | 1.586262e-01 | 0.800 |
R-HSA-177929 | Signaling by EGFR | 1.665630e-01 | 0.778 |
R-HSA-1483249 | Inositol phosphate metabolism | 1.700447e-01 | 0.769 |
R-HSA-73857 | RNA Polymerase II Transcription | 1.224294e-01 | 0.912 |
R-HSA-8877330 | RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | 1.766321e-01 | 0.753 |
R-HSA-5689880 | Ub-specific processing proteases | 1.784908e-01 | 0.748 |
R-HSA-74749 | Signal attenuation | 1.380894e-01 | 0.860 |
R-HSA-210990 | PECAM1 interactions | 1.478901e-01 | 0.830 |
R-HSA-392517 | Rap1 signalling | 2.400018e-01 | 0.620 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 2.072673e-01 | 0.683 |
R-HSA-212436 | Generic Transcription Pathway | 1.318341e-01 | 0.880 |
R-HSA-73887 | Death Receptor Signaling | 1.356894e-01 | 0.867 |
R-HSA-1169408 | ISG15 antiviral mechanism | 2.452153e-01 | 0.610 |
R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 2.044097e-01 | 0.689 |
R-HSA-69206 | G1/S Transition | 2.161098e-01 | 0.665 |
R-HSA-430116 | GP1b-IX-V activation signalling | 1.281766e-01 | 0.892 |
R-HSA-174403 | Glutathione synthesis and recycling | 2.656525e-01 | 0.576 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 1.762493e-01 | 0.754 |
R-HSA-1266738 | Developmental Biology | 2.440076e-01 | 0.613 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 2.310183e-01 | 0.636 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 2.098925e-01 | 0.678 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 2.014142e-01 | 0.696 |
R-HSA-389948 | Co-inhibition by PD-1 | 2.422000e-01 | 0.616 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 1.827950e-01 | 0.738 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 1.827950e-01 | 0.738 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 1.827950e-01 | 0.738 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 1.827950e-01 | 0.738 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 1.951161e-01 | 0.710 |
R-HSA-8848021 | Signaling by PTK6 | 1.951161e-01 | 0.710 |
R-HSA-9856532 | Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | 2.400018e-01 | 0.620 |
R-HSA-1483255 | PI Metabolism | 1.402888e-01 | 0.853 |
R-HSA-1362277 | Transcription of E2F targets under negative control by DREAM complex | 2.486495e-01 | 0.604 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 1.199012e-01 | 0.921 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 2.873433e-01 | 0.542 |
R-HSA-4086398 | Ca2+ pathway | 2.368060e-01 | 0.626 |
R-HSA-210993 | Tie2 Signaling | 2.312551e-01 | 0.636 |
R-HSA-1855183 | Synthesis of IP2, IP, and Ins in the cytosol | 3.065041e-01 | 0.514 |
R-HSA-8983711 | OAS antiviral response | 1.671602e-01 | 0.777 |
R-HSA-9909396 | Circadian clock | 2.400539e-01 | 0.620 |
R-HSA-5633007 | Regulation of TP53 Activity | 1.480565e-01 | 0.830 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 1.827950e-01 | 0.738 |
R-HSA-446203 | Asparagine N-linked glycosylation | 1.370080e-01 | 0.863 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 1.665630e-01 | 0.778 |
R-HSA-75153 | Apoptotic execution phase | 1.273248e-01 | 0.895 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 2.957544e-01 | 0.529 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 2.227546e-01 | 0.652 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 3.143990e-01 | 0.503 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 3.143990e-01 | 0.503 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 3.143990e-01 | 0.503 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 3.143990e-01 | 0.503 |
R-HSA-389357 | CD28 dependent PI3K/Akt signaling | 3.143990e-01 | 0.503 |
R-HSA-193807 | Synthesis of bile acids and bile salts via 27-hydroxycholesterol | 3.143990e-01 | 0.503 |
R-HSA-381070 | IRE1alpha activates chaperones | 3.208884e-01 | 0.494 |
R-HSA-167287 | HIV elongation arrest and recovery | 3.222046e-01 | 0.492 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 3.222046e-01 | 0.492 |
R-HSA-113418 | Formation of the Early Elongation Complex | 3.222046e-01 | 0.492 |
R-HSA-167158 | Formation of the HIV-1 Early Elongation Complex | 3.222046e-01 | 0.492 |
R-HSA-72086 | mRNA Capping | 3.299217e-01 | 0.482 |
R-HSA-9006335 | Signaling by Erythropoietin | 3.299217e-01 | 0.482 |
R-HSA-9006936 | Signaling by TGFB family members | 3.325487e-01 | 0.478 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 3.333782e-01 | 0.477 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 3.375515e-01 | 0.472 |
R-HSA-380972 | Energy dependent regulation of mTOR by LKB1-AMPK | 3.375515e-01 | 0.472 |
R-HSA-68962 | Activation of the pre-replicative complex | 3.375515e-01 | 0.472 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 3.375515e-01 | 0.472 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 3.375515e-01 | 0.472 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 3.450948e-01 | 0.462 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 3.450948e-01 | 0.462 |
R-HSA-182971 | EGFR downregulation | 3.450948e-01 | 0.462 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 3.458023e-01 | 0.461 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 3.499274e-01 | 0.456 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 3.499274e-01 | 0.456 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 3.525527e-01 | 0.453 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 3.599262e-01 | 0.444 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 3.599262e-01 | 0.444 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 3.599262e-01 | 0.444 |
R-HSA-397795 | G-protein beta:gamma signalling | 3.599262e-01 | 0.444 |
R-HSA-159418 | Recycling of bile acids and salts | 3.599262e-01 | 0.444 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 3.599262e-01 | 0.444 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 3.666852e-01 | 0.436 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 3.672161e-01 | 0.435 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 3.672161e-01 | 0.435 |
R-HSA-5223345 | Miscellaneous transport and binding events | 3.672161e-01 | 0.435 |
R-HSA-114508 | Effects of PIP2 hydrolysis | 3.672161e-01 | 0.435 |
R-HSA-9842860 | Regulation of endogenous retroelements | 3.704151e-01 | 0.431 |
R-HSA-5673000 | RAF activation | 3.744234e-01 | 0.427 |
R-HSA-9843970 | Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | 3.744234e-01 | 0.427 |
R-HSA-180746 | Nuclear import of Rev protein | 3.744234e-01 | 0.427 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 3.744234e-01 | 0.427 |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian expression | 3.744234e-01 | 0.427 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 3.744234e-01 | 0.427 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 3.815491e-01 | 0.418 |
R-HSA-5688426 | Deubiquitination | 3.848774e-01 | 0.415 |
R-HSA-74158 | RNA Polymerase III Transcription | 3.885941e-01 | 0.411 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 3.885941e-01 | 0.411 |
R-HSA-9682385 | FLT3 signaling in disease | 3.885941e-01 | 0.411 |
R-HSA-114604 | GPVI-mediated activation cascade | 3.885941e-01 | 0.411 |
R-HSA-69620 | Cell Cycle Checkpoints | 3.925953e-01 | 0.406 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 3.955592e-01 | 0.403 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 3.955592e-01 | 0.403 |
R-HSA-419037 | NCAM1 interactions | 3.955592e-01 | 0.403 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 3.955592e-01 | 0.403 |
R-HSA-2672351 | Stimuli-sensing channels | 3.986575e-01 | 0.399 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 4.024454e-01 | 0.395 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 4.092536e-01 | 0.388 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 4.092536e-01 | 0.388 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 4.092536e-01 | 0.388 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 4.092536e-01 | 0.388 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 4.159847e-01 | 0.381 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 4.159847e-01 | 0.381 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 4.159847e-01 | 0.381 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 4.159847e-01 | 0.381 |
R-HSA-167169 | HIV Transcription Elongation | 4.159847e-01 | 0.381 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 4.159847e-01 | 0.381 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 4.159847e-01 | 0.381 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 4.159847e-01 | 0.381 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 4.159847e-01 | 0.381 |
R-HSA-451927 | Interleukin-2 family signaling | 4.159847e-01 | 0.381 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 4.218122e-01 | 0.375 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 4.226394e-01 | 0.374 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 4.226394e-01 | 0.374 |
R-HSA-9607240 | FLT3 Signaling | 4.226394e-01 | 0.374 |
R-HSA-9656223 | Signaling by RAF1 mutants | 4.292188e-01 | 0.367 |
R-HSA-5674135 | MAP2K and MAPK activation | 4.292188e-01 | 0.367 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 4.292188e-01 | 0.367 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 4.292188e-01 | 0.367 |
R-HSA-6811438 | Intra-Golgi traffic | 4.292188e-01 | 0.367 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 4.340821e-01 | 0.362 |
R-HSA-165159 | MTOR signalling | 4.357235e-01 | 0.361 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 4.357235e-01 | 0.361 |
R-HSA-1592230 | Mitochondrial biogenesis | 4.418041e-01 | 0.355 |
R-HSA-1433557 | Signaling by SCF-KIT | 4.421545e-01 | 0.354 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 4.456435e-01 | 0.351 |
R-HSA-3214858 | RMTs methylate histone arginines | 4.485127e-01 | 0.348 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 4.485127e-01 | 0.348 |
R-HSA-373752 | Netrin-1 signaling | 4.485127e-01 | 0.348 |
R-HSA-375280 | Amine ligand-binding receptors | 4.485127e-01 | 0.348 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 4.547987e-01 | 0.342 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 4.547987e-01 | 0.342 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 4.610135e-01 | 0.336 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 4.610135e-01 | 0.336 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 4.610135e-01 | 0.336 |
R-HSA-6802949 | Signaling by RAS mutants | 4.610135e-01 | 0.336 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 4.610135e-01 | 0.336 |
R-HSA-9839373 | Signaling by TGFBR3 | 4.610135e-01 | 0.336 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 4.610135e-01 | 0.336 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 4.671578e-01 | 0.331 |
R-HSA-389356 | Co-stimulation by CD28 | 4.732325e-01 | 0.325 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 4.792383e-01 | 0.319 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 4.792383e-01 | 0.319 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 4.816296e-01 | 0.317 |
R-HSA-1257604 | PIP3 activates AKT signaling | 4.858989e-01 | 0.313 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 4.910463e-01 | 0.309 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 4.968500e-01 | 0.304 |
R-HSA-72187 | mRNA 3'-end processing | 4.968500e-01 | 0.304 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 4.968500e-01 | 0.304 |
R-HSA-68949 | Orc1 removal from chromatin | 4.968500e-01 | 0.304 |
R-HSA-9931269 | AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 4.968500e-01 | 0.304 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 5.025879e-01 | 0.299 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 5.025879e-01 | 0.299 |
R-HSA-445355 | Smooth Muscle Contraction | 5.025879e-01 | 0.299 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 5.138693e-01 | 0.289 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 5.194141e-01 | 0.284 |
R-HSA-193648 | NRAGE signals death through JNK | 5.194141e-01 | 0.284 |
R-HSA-75893 | TNF signaling | 5.194141e-01 | 0.284 |
R-HSA-8951664 | Neddylation | 5.208274e-01 | 0.283 |
R-HSA-163685 | Integration of energy metabolism | 5.226750e-01 | 0.282 |
R-HSA-9018519 | Estrogen-dependent gene expression | 5.226750e-01 | 0.282 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 5.226750e-01 | 0.282 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 5.248961e-01 | 0.280 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 5.248961e-01 | 0.280 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 5.303159e-01 | 0.275 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 5.330856e-01 | 0.273 |
R-HSA-194441 | Metabolism of non-coding RNA | 5.356742e-01 | 0.271 |
R-HSA-191859 | snRNP Assembly | 5.356742e-01 | 0.271 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 5.409716e-01 | 0.267 |
R-HSA-5362517 | Signaling by Retinoic Acid | 5.409716e-01 | 0.267 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 5.409716e-01 | 0.267 |
R-HSA-156590 | Glutathione conjugation | 5.409716e-01 | 0.267 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 5.462090e-01 | 0.263 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 5.462090e-01 | 0.263 |
R-HSA-211976 | Endogenous sterols | 5.462090e-01 | 0.263 |
R-HSA-450294 | MAP kinase activation | 5.462090e-01 | 0.263 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 5.467250e-01 | 0.262 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 5.467250e-01 | 0.262 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 5.500914e-01 | 0.260 |
R-HSA-72312 | rRNA processing | 5.508857e-01 | 0.259 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 5.513869e-01 | 0.259 |
R-HSA-6784531 | tRNA processing in the nucleus | 5.513869e-01 | 0.259 |
R-HSA-375165 | NCAM signaling for neurite out-growth | 5.513869e-01 | 0.259 |
R-HSA-9707616 | Heme signaling | 5.513869e-01 | 0.259 |
R-HSA-9824446 | Viral Infection Pathways | 5.542877e-01 | 0.256 |
R-HSA-597592 | Post-translational protein modification | 5.543201e-01 | 0.256 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 5.565061e-01 | 0.255 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 5.565061e-01 | 0.255 |
R-HSA-74751 | Insulin receptor signalling cascade | 5.615671e-01 | 0.251 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 5.615671e-01 | 0.251 |
R-HSA-8939211 | ESR-mediated signaling | 5.641797e-01 | 0.249 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 5.665708e-01 | 0.247 |
R-HSA-69242 | S Phase | 5.666604e-01 | 0.247 |
R-HSA-157118 | Signaling by NOTCH | 5.720414e-01 | 0.243 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 5.763904e-01 | 0.239 |
R-HSA-9830369 | Kidney development | 5.764082e-01 | 0.239 |
R-HSA-193368 | Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 5.764082e-01 | 0.239 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 5.795983e-01 | 0.237 |
R-HSA-167172 | Transcription of the HIV genome | 5.812434e-01 | 0.236 |
R-HSA-204005 | COPII-mediated vesicle transport | 5.907496e-01 | 0.229 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 5.907496e-01 | 0.229 |
R-HSA-448424 | Interleukin-17 signaling | 5.907496e-01 | 0.229 |
R-HSA-75105 | Fatty acyl-CoA biosynthesis | 5.907496e-01 | 0.229 |
R-HSA-9006925 | Intracellular signaling by second messengers | 5.951461e-01 | 0.225 |
R-HSA-9610379 | HCMV Late Events | 5.953718e-01 | 0.225 |
R-HSA-162587 | HIV Life Cycle | 5.953718e-01 | 0.225 |
R-HSA-453276 | Regulation of mitotic cell cycle | 5.954219e-01 | 0.225 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 5.954219e-01 | 0.225 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 6.000411e-01 | 0.222 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 6.000411e-01 | 0.222 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 6.000411e-01 | 0.222 |
R-HSA-69052 | Switching of origins to a post-replicative state | 6.046079e-01 | 0.219 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 6.046079e-01 | 0.219 |
R-HSA-5683057 | MAPK family signaling cascades | 6.059474e-01 | 0.218 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 6.091229e-01 | 0.215 |
R-HSA-109581 | Apoptosis | 6.107013e-01 | 0.214 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 6.223623e-01 | 0.206 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 6.266756e-01 | 0.203 |
R-HSA-416482 | G alpha (12/13) signalling events | 6.266756e-01 | 0.203 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 6.309398e-01 | 0.200 |
R-HSA-5579029 | Metabolic disorders of biological oxidation enzymes | 6.309398e-01 | 0.200 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 6.393219e-01 | 0.194 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 6.393236e-01 | 0.194 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 6.400311e-01 | 0.194 |
R-HSA-9711123 | Cellular response to chemical stress | 6.410738e-01 | 0.193 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 6.475179e-01 | 0.189 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 6.515453e-01 | 0.186 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 6.548144e-01 | 0.184 |
R-HSA-6802957 | Oncogenic MAPK signaling | 6.555270e-01 | 0.183 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 6.594634e-01 | 0.181 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 6.633551e-01 | 0.178 |
R-HSA-446728 | Cell junction organization | 6.637651e-01 | 0.178 |
R-HSA-112310 | Neurotransmitter release cycle | 6.784845e-01 | 0.168 |
R-HSA-202424 | Downstream TCR signaling | 6.784845e-01 | 0.168 |
R-HSA-983712 | Ion channel transport | 6.884252e-01 | 0.162 |
R-HSA-2682334 | EPH-Ephrin signaling | 6.893859e-01 | 0.162 |
R-HSA-74752 | Signaling by Insulin receptor | 6.893859e-01 | 0.162 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 6.893859e-01 | 0.162 |
R-HSA-68867 | Assembly of the pre-replicative complex | 6.929374e-01 | 0.159 |
R-HSA-1483257 | Phospholipid metabolism | 6.999311e-01 | 0.155 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 7.067440e-01 | 0.151 |
R-HSA-157579 | Telomere Maintenance | 7.100981e-01 | 0.149 |
R-HSA-8957275 | Post-translational protein phosphorylation | 7.134140e-01 | 0.147 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 7.134140e-01 | 0.147 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 7.134140e-01 | 0.147 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 7.134140e-01 | 0.147 |
R-HSA-192105 | Synthesis of bile acids and bile salts | 7.166922e-01 | 0.145 |
R-HSA-70171 | Glycolysis | 7.199331e-01 | 0.143 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 7.222839e-01 | 0.141 |
R-HSA-9020702 | Interleukin-1 signaling | 7.231371e-01 | 0.141 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 7.231371e-01 | 0.141 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 7.263046e-01 | 0.139 |
R-HSA-5357801 | Programmed Cell Death | 7.291250e-01 | 0.137 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 7.325320e-01 | 0.135 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 7.347592e-01 | 0.134 |
R-HSA-163125 | Post-translational modification: synthesis of GPI-anchored proteins | 7.355927e-01 | 0.133 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 7.386185e-01 | 0.132 |
R-HSA-1500931 | Cell-Cell communication | 7.404599e-01 | 0.130 |
R-HSA-69239 | Synthesis of DNA | 7.445672e-01 | 0.128 |
R-HSA-211000 | Gene Silencing by RNA | 7.445672e-01 | 0.128 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 7.474908e-01 | 0.126 |
R-HSA-69002 | DNA Replication Pre-Initiation | 7.503812e-01 | 0.125 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 7.503812e-01 | 0.125 |
R-HSA-449147 | Signaling by Interleukins | 7.508837e-01 | 0.124 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 7.532386e-01 | 0.123 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 7.532386e-01 | 0.123 |
R-HSA-194068 | Bile acid and bile salt metabolism | 7.532386e-01 | 0.123 |
R-HSA-202403 | TCR signaling | 7.532386e-01 | 0.123 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 7.616173e-01 | 0.118 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 7.643468e-01 | 0.117 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 7.670452e-01 | 0.115 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 7.697129e-01 | 0.114 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 7.697129e-01 | 0.114 |
R-HSA-162906 | HIV Infection | 7.750560e-01 | 0.111 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 7.769735e-01 | 0.110 |
R-HSA-70326 | Glucose metabolism | 7.775351e-01 | 0.109 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 7.826024e-01 | 0.106 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 7.826024e-01 | 0.106 |
R-HSA-73886 | Chromosome Maintenance | 7.875550e-01 | 0.104 |
R-HSA-3371556 | Cellular response to heat stress | 7.875550e-01 | 0.104 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 7.875550e-01 | 0.104 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 7.899890e-01 | 0.102 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 7.899890e-01 | 0.102 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 7.923953e-01 | 0.101 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 7.936000e-01 | 0.100 |
R-HSA-162909 | Host Interactions of HIV factors | 7.947742e-01 | 0.100 |
R-HSA-9694516 | SARS-CoV-2 Infection | 7.952753e-01 | 0.099 |
R-HSA-168256 | Immune System | 8.034589e-01 | 0.095 |
R-HSA-114608 | Platelet degranulation | 8.040217e-01 | 0.095 |
R-HSA-9843745 | Adipogenesis | 8.150002e-01 | 0.089 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 8.192184e-01 | 0.087 |
R-HSA-6807070 | PTEN Regulation | 8.332426e-01 | 0.079 |
R-HSA-9734767 | Developmental Cell Lineages | 8.356558e-01 | 0.078 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 8.514203e-01 | 0.070 |
R-HSA-9856651 | MITF-M-dependent gene expression | 8.548120e-01 | 0.068 |
R-HSA-9679191 | Potential therapeutics for SARS | 8.548120e-01 | 0.068 |
R-HSA-446652 | Interleukin-1 family signaling | 8.581268e-01 | 0.066 |
R-HSA-69306 | DNA Replication | 8.597558e-01 | 0.066 |
R-HSA-1989781 | PPARA activates gene expression | 8.629583e-01 | 0.064 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 8.629583e-01 | 0.064 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 8.660880e-01 | 0.062 |
R-HSA-8978868 | Fatty acid metabolism | 8.692952e-01 | 0.061 |
R-HSA-5673001 | RAF/MAP kinase cascade | 8.698494e-01 | 0.061 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 8.778748e-01 | 0.057 |
R-HSA-211897 | Cytochrome P450 - arranged by substrate type | 8.807017e-01 | 0.055 |
R-HSA-5619102 | SLC transporter disorders | 8.807017e-01 | 0.055 |
R-HSA-1643685 | Disease | 8.828722e-01 | 0.054 |
R-HSA-72306 | tRNA processing | 8.860928e-01 | 0.053 |
R-HSA-418555 | G alpha (s) signalling events | 8.874023e-01 | 0.052 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 8.899765e-01 | 0.051 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 8.899765e-01 | 0.051 |
R-HSA-168255 | Influenza Infection | 8.973531e-01 | 0.047 |
R-HSA-9679506 | SARS-CoV Infections | 8.978926e-01 | 0.047 |
R-HSA-168898 | Toll-like Receptor Cascades | 9.106627e-01 | 0.041 |
R-HSA-6798695 | Neutrophil degranulation | 9.125023e-01 | 0.040 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 9.156881e-01 | 0.038 |
R-HSA-397014 | Muscle contraction | 9.307628e-01 | 0.031 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 9.315608e-01 | 0.031 |
R-HSA-418990 | Adherens junctions interactions | 9.354161e-01 | 0.029 |
R-HSA-156580 | Phase II - Conjugation of compounds | 9.493850e-01 | 0.023 |
R-HSA-5619115 | Disorders of transmembrane transporters | 9.538767e-01 | 0.021 |
R-HSA-421270 | Cell-cell junction organization | 9.559715e-01 | 0.020 |
R-HSA-5663205 | Infectious disease | 9.609337e-01 | 0.017 |
R-HSA-416476 | G alpha (q) signalling events | 9.621478e-01 | 0.017 |
R-HSA-211945 | Phase I - Functionalization of compounds | 9.678384e-01 | 0.014 |
R-HSA-392499 | Metabolism of proteins | 9.764517e-01 | 0.010 |
R-HSA-8957322 | Metabolism of steroids | 9.811885e-01 | 0.008 |
R-HSA-388396 | GPCR downstream signalling | 9.820913e-01 | 0.008 |
R-HSA-211859 | Biological oxidations | 9.866659e-01 | 0.006 |
R-HSA-372790 | Signaling by GPCR | 9.912813e-01 | 0.004 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 9.918043e-01 | 0.004 |
R-HSA-5668914 | Diseases of metabolism | 9.944369e-01 | 0.002 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 9.959981e-01 | 0.002 |
R-HSA-168249 | Innate Immune System | 9.985035e-01 | 0.001 |
R-HSA-500792 | GPCR ligand binding | 9.991795e-01 | 0.000 |
R-HSA-382551 | Transport of small molecules | 9.993582e-01 | 0.000 |
R-HSA-556833 | Metabolism of lipids | 9.996396e-01 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000e+00 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CDK18 |
0.816 | 0.750 | 1 | 0.906 |
HIPK2 |
0.811 | 0.672 | 1 | 0.896 |
CDK19 |
0.810 | 0.747 | 1 | 0.894 |
CDK16 |
0.805 | 0.724 | 1 | 0.911 |
KIS |
0.805 | 0.593 | 1 | 0.866 |
CDK8 |
0.804 | 0.738 | 1 | 0.873 |
P38B |
0.804 | 0.773 | 1 | 0.882 |
CDK17 |
0.804 | 0.720 | 1 | 0.915 |
P38G |
0.801 | 0.715 | 1 | 0.917 |
P38D |
0.801 | 0.709 | 1 | 0.946 |
CDK1 |
0.801 | 0.686 | 1 | 0.890 |
ERK1 |
0.800 | 0.738 | 1 | 0.891 |
CDK3 |
0.797 | 0.611 | 1 | 0.917 |
MAK |
0.797 | 0.662 | -2 | 0.916 |
CDK7 |
0.796 | 0.688 | 1 | 0.885 |
DYRK2 |
0.795 | 0.644 | 1 | 0.844 |
CDK5 |
0.795 | 0.690 | 1 | 0.868 |
JNK2 |
0.794 | 0.705 | 1 | 0.900 |
P38A |
0.794 | 0.769 | 1 | 0.839 |
CDK13 |
0.794 | 0.664 | 1 | 0.893 |
CDK12 |
0.794 | 0.670 | 1 | 0.902 |
CDK14 |
0.792 | 0.708 | 1 | 0.876 |
DYRK4 |
0.792 | 0.630 | 1 | 0.907 |
CDK10 |
0.790 | 0.647 | 1 | 0.889 |
CLK3 |
0.786 | 0.438 | 1 | 0.648 |
HIPK4 |
0.786 | 0.513 | 1 | 0.680 |
JNK3 |
0.785 | 0.679 | 1 | 0.887 |
HIPK1 |
0.784 | 0.587 | 1 | 0.827 |
DYRK1B |
0.779 | 0.591 | 1 | 0.867 |
DYRK1A |
0.778 | 0.574 | 1 | 0.811 |
CDK9 |
0.778 | 0.625 | 1 | 0.885 |
JNK1 |
0.775 | 0.625 | 1 | 0.896 |
CDK6 |
0.774 | 0.654 | 1 | 0.889 |
SRPK1 |
0.773 | 0.305 | -3 | 0.677 |
CDK4 |
0.772 | 0.667 | 1 | 0.909 |
ERK2 |
0.772 | 0.664 | 1 | 0.855 |
HIPK3 |
0.771 | 0.574 | 1 | 0.795 |
CLK2 |
0.770 | 0.351 | -3 | 0.666 |
ICK |
0.770 | 0.522 | -3 | 0.737 |
NLK |
0.770 | 0.593 | 1 | 0.676 |
CDKL5 |
0.769 | 0.351 | -3 | 0.701 |
DYRK3 |
0.768 | 0.474 | 1 | 0.797 |
MOK |
0.765 | 0.548 | 1 | 0.743 |
ERK5 |
0.763 | 0.373 | 1 | 0.605 |
MTOR |
0.762 | 0.366 | 1 | 0.474 |
SRPK2 |
0.762 | 0.249 | -3 | 0.606 |
CDKL1 |
0.759 | 0.306 | -3 | 0.709 |
CDK2 |
0.757 | 0.473 | 1 | 0.799 |
CLK4 |
0.755 | 0.299 | -3 | 0.672 |
CLK1 |
0.754 | 0.323 | -3 | 0.636 |
SRPK3 |
0.753 | 0.237 | -3 | 0.651 |
COT |
0.750 | -0.011 | 2 | 0.808 |
PRP4 |
0.747 | 0.392 | -3 | 0.716 |
ATR |
0.742 | 0.074 | 1 | 0.429 |
CDC7 |
0.739 | -0.012 | 1 | 0.347 |
MOS |
0.739 | 0.030 | 1 | 0.393 |
NDR2 |
0.739 | 0.040 | -3 | 0.726 |
PIM3 |
0.738 | -0.003 | -3 | 0.742 |
PRPK |
0.735 | -0.010 | -1 | 0.751 |
MPSK1 |
0.733 | 0.297 | 1 | 0.395 |
ERK7 |
0.732 | 0.233 | 2 | 0.499 |
GRK7 |
0.731 | 0.073 | 1 | 0.333 |
TBK1 |
0.731 | -0.070 | 1 | 0.272 |
PRKD1 |
0.731 | 0.007 | -3 | 0.708 |
MST4 |
0.731 | 0.031 | 2 | 0.764 |
AURC |
0.730 | 0.022 | -2 | 0.535 |
RSK2 |
0.730 | 0.005 | -3 | 0.677 |
CAMK1B |
0.729 | -0.022 | -3 | 0.736 |
CHAK2 |
0.728 | 0.001 | -1 | 0.678 |
GRK1 |
0.728 | -0.015 | -2 | 0.540 |
PIM1 |
0.728 | 0.023 | -3 | 0.689 |
SKMLCK |
0.728 | -0.016 | -2 | 0.652 |
RAF1 |
0.728 | -0.118 | 1 | 0.324 |
WNK1 |
0.728 | -0.017 | -2 | 0.649 |
IKKB |
0.727 | -0.176 | -2 | 0.478 |
IKKE |
0.726 | -0.128 | 1 | 0.268 |
NDR1 |
0.726 | -0.023 | -3 | 0.712 |
BMPR2 |
0.726 | -0.130 | -2 | 0.597 |
P90RSK |
0.726 | 0.005 | -3 | 0.685 |
PRKD2 |
0.726 | -0.005 | -3 | 0.650 |
PDHK4 |
0.726 | -0.088 | 1 | 0.387 |
GCN2 |
0.725 | -0.175 | 2 | 0.702 |
PKCD |
0.725 | 0.026 | 2 | 0.707 |
PKACB |
0.725 | 0.030 | -2 | 0.526 |
NUAK2 |
0.725 | 0.013 | -3 | 0.724 |
PKCA |
0.724 | 0.079 | 2 | 0.643 |
PKN2 |
0.724 | -0.022 | -3 | 0.709 |
IRE1 |
0.724 | 0.009 | 1 | 0.334 |
GSK3A |
0.723 | 0.179 | 4 | 0.375 |
MLK3 |
0.723 | 0.039 | 2 | 0.661 |
CAMLCK |
0.723 | -0.002 | -2 | 0.629 |
MLK1 |
0.723 | -0.055 | 2 | 0.728 |
DAPK2 |
0.722 | -0.009 | -3 | 0.744 |
NIK |
0.722 | -0.032 | -3 | 0.744 |
NEK6 |
0.722 | -0.092 | -2 | 0.562 |
PKACG |
0.722 | -0.022 | -2 | 0.549 |
DNAPK |
0.722 | 0.043 | 1 | 0.399 |
PKN3 |
0.722 | -0.037 | -3 | 0.704 |
CK1E |
0.722 | 0.081 | -3 | 0.636 |
PKCG |
0.722 | 0.042 | 2 | 0.656 |
MAPKAPK2 |
0.721 | -0.021 | -3 | 0.629 |
GRK5 |
0.721 | -0.110 | -3 | 0.768 |
RSK3 |
0.720 | -0.019 | -3 | 0.664 |
FAM20C |
0.720 | 0.012 | 2 | 0.592 |
ULK2 |
0.720 | -0.172 | 2 | 0.696 |
MARK4 |
0.720 | -0.005 | 4 | 0.707 |
PRKX |
0.720 | 0.033 | -3 | 0.597 |
DSTYK |
0.720 | -0.178 | 2 | 0.804 |
RIPK3 |
0.720 | -0.083 | 3 | 0.653 |
TGFBR2 |
0.720 | -0.116 | -2 | 0.519 |
CAMK2G |
0.719 | -0.110 | 2 | 0.733 |
PDHK1 |
0.718 | -0.149 | 1 | 0.365 |
ATM |
0.718 | -0.033 | 1 | 0.397 |
PKCB |
0.718 | 0.011 | 2 | 0.652 |
PAK1 |
0.718 | -0.016 | -2 | 0.639 |
MNK2 |
0.718 | -0.010 | -2 | 0.595 |
AKT2 |
0.717 | 0.038 | -3 | 0.603 |
MAPKAPK3 |
0.717 | -0.054 | -3 | 0.651 |
NIM1 |
0.717 | 0.035 | 3 | 0.689 |
MLK2 |
0.716 | -0.028 | 2 | 0.736 |
LATS2 |
0.716 | -0.050 | -5 | 0.703 |
CK1D |
0.716 | 0.081 | -3 | 0.594 |
RSK4 |
0.715 | 0.011 | -3 | 0.660 |
IKKA |
0.715 | -0.118 | -2 | 0.482 |
AMPKA1 |
0.715 | -0.044 | -3 | 0.721 |
BMPR1B |
0.715 | -0.063 | 1 | 0.292 |
NEK7 |
0.714 | -0.203 | -3 | 0.731 |
LATS1 |
0.713 | 0.017 | -3 | 0.741 |
CAMK2D |
0.713 | -0.088 | -3 | 0.705 |
BCKDK |
0.713 | -0.117 | -1 | 0.702 |
P70S6KB |
0.713 | -0.042 | -3 | 0.677 |
SMG1 |
0.713 | -0.036 | 1 | 0.418 |
PKCZ |
0.713 | 0.002 | 2 | 0.692 |
MNK1 |
0.713 | -0.008 | -2 | 0.590 |
PAK3 |
0.713 | -0.053 | -2 | 0.612 |
AMPKA2 |
0.712 | -0.026 | -3 | 0.692 |
PAK6 |
0.712 | -0.008 | -2 | 0.559 |
MSK2 |
0.712 | -0.029 | -3 | 0.657 |
PKG2 |
0.712 | -0.020 | -2 | 0.523 |
AURB |
0.712 | -0.015 | -2 | 0.527 |
DLK |
0.711 | -0.134 | 1 | 0.329 |
CK1G1 |
0.711 | 0.037 | -3 | 0.622 |
SGK3 |
0.711 | 0.011 | -3 | 0.651 |
MLK4 |
0.711 | -0.018 | 2 | 0.646 |
PRKD3 |
0.711 | -0.015 | -3 | 0.630 |
CAMK2A |
0.711 | -0.031 | 2 | 0.722 |
IRE2 |
0.711 | -0.019 | 2 | 0.672 |
GRK6 |
0.710 | -0.129 | 1 | 0.317 |
PINK1 |
0.710 | 0.107 | 1 | 0.533 |
AURA |
0.710 | -0.013 | -2 | 0.520 |
MASTL |
0.710 | -0.140 | -2 | 0.557 |
CK1A2 |
0.710 | 0.065 | -3 | 0.595 |
VRK2 |
0.710 | 0.058 | 1 | 0.434 |
WNK3 |
0.709 | -0.176 | 1 | 0.331 |
RIPK1 |
0.709 | -0.144 | 1 | 0.319 |
NEK9 |
0.709 | -0.160 | 2 | 0.738 |
PIM2 |
0.708 | 0.014 | -3 | 0.641 |
TSSK1 |
0.708 | -0.045 | -3 | 0.740 |
QSK |
0.708 | 0.005 | 4 | 0.691 |
PHKG1 |
0.708 | -0.054 | -3 | 0.704 |
PKR |
0.708 | -0.055 | 1 | 0.359 |
CAMK2B |
0.707 | -0.063 | 2 | 0.711 |
MSK1 |
0.707 | -0.022 | -3 | 0.649 |
PKCH |
0.707 | -0.017 | 2 | 0.630 |
AKT1 |
0.707 | 0.026 | -3 | 0.613 |
TSSK2 |
0.707 | -0.089 | -5 | 0.814 |
TTBK2 |
0.706 | -0.149 | 2 | 0.617 |
GRK4 |
0.706 | -0.159 | -2 | 0.545 |
TGFBR1 |
0.706 | -0.096 | -2 | 0.509 |
ALK4 |
0.706 | -0.107 | -2 | 0.533 |
PAK2 |
0.705 | -0.051 | -2 | 0.617 |
TLK2 |
0.705 | -0.115 | 1 | 0.342 |
HUNK |
0.705 | -0.199 | 2 | 0.719 |
TAO3 |
0.705 | 0.061 | 1 | 0.340 |
PKACA |
0.705 | 0.006 | -2 | 0.496 |
MST3 |
0.705 | 0.035 | 2 | 0.751 |
ULK1 |
0.704 | -0.205 | -3 | 0.675 |
QIK |
0.704 | -0.047 | -3 | 0.703 |
CAMK4 |
0.703 | -0.119 | -3 | 0.684 |
MYLK4 |
0.703 | -0.046 | -2 | 0.579 |
BUB1 |
0.703 | 0.088 | -5 | 0.821 |
CHAK1 |
0.702 | -0.097 | 2 | 0.702 |
SIK |
0.702 | -0.013 | -3 | 0.640 |
ACVR2A |
0.702 | -0.118 | -2 | 0.506 |
NUAK1 |
0.702 | -0.050 | -3 | 0.653 |
MEK1 |
0.702 | -0.114 | 2 | 0.756 |
ANKRD3 |
0.701 | -0.219 | 1 | 0.352 |
GSK3B |
0.701 | 0.035 | 4 | 0.369 |
YSK4 |
0.700 | -0.151 | 1 | 0.290 |
PKCE |
0.700 | 0.040 | 2 | 0.641 |
GRK2 |
0.700 | -0.080 | -2 | 0.478 |
MARK3 |
0.700 | -0.022 | 4 | 0.642 |
ACVR2B |
0.700 | -0.129 | -2 | 0.509 |
PKCT |
0.699 | -0.014 | 2 | 0.638 |
NEK2 |
0.699 | -0.130 | 2 | 0.717 |
DRAK1 |
0.699 | -0.106 | 1 | 0.281 |
MELK |
0.699 | -0.095 | -3 | 0.671 |
PASK |
0.698 | -0.009 | -3 | 0.763 |
DCAMKL1 |
0.697 | -0.040 | -3 | 0.669 |
PKCI |
0.697 | 0.001 | 2 | 0.660 |
AKT3 |
0.697 | 0.026 | -3 | 0.561 |
MEKK2 |
0.697 | -0.042 | 2 | 0.712 |
PLK1 |
0.697 | -0.185 | -2 | 0.522 |
PLK4 |
0.697 | -0.091 | 2 | 0.537 |
PAK5 |
0.696 | -0.026 | -2 | 0.535 |
WNK4 |
0.696 | -0.057 | -2 | 0.637 |
MEK5 |
0.696 | -0.085 | 2 | 0.733 |
CAMK1G |
0.696 | -0.053 | -3 | 0.645 |
MAPKAPK5 |
0.695 | -0.102 | -3 | 0.618 |
SGK1 |
0.695 | 0.039 | -3 | 0.542 |
ALK2 |
0.694 | -0.132 | -2 | 0.508 |
ZAK |
0.694 | -0.101 | 1 | 0.299 |
MEKK3 |
0.694 | -0.115 | 1 | 0.318 |
IRAK4 |
0.694 | -0.080 | 1 | 0.315 |
MARK2 |
0.693 | -0.046 | 4 | 0.605 |
PAK4 |
0.693 | -0.026 | -2 | 0.552 |
MEKK1 |
0.692 | -0.104 | 1 | 0.336 |
PHKG2 |
0.692 | -0.051 | -3 | 0.657 |
TAO2 |
0.692 | 0.018 | 2 | 0.756 |
GRK3 |
0.692 | -0.073 | -2 | 0.441 |
BRSK1 |
0.692 | -0.083 | -3 | 0.665 |
BMPR1A |
0.692 | -0.097 | 1 | 0.276 |
TNIK |
0.692 | 0.047 | 3 | 0.842 |
GCK |
0.692 | 0.017 | 1 | 0.319 |
PLK3 |
0.691 | -0.149 | 2 | 0.688 |
DAPK3 |
0.691 | -0.024 | -3 | 0.691 |
SMMLCK |
0.691 | -0.039 | -3 | 0.694 |
NEK5 |
0.690 | -0.135 | 1 | 0.341 |
CHK1 |
0.690 | -0.085 | -3 | 0.673 |
HRI |
0.690 | -0.159 | -2 | 0.563 |
CK2A2 |
0.690 | -0.038 | 1 | 0.268 |
PERK |
0.690 | -0.175 | -2 | 0.535 |
BRSK2 |
0.690 | -0.099 | -3 | 0.671 |
MAP3K15 |
0.690 | 0.047 | 1 | 0.309 |
HGK |
0.690 | 0.022 | 3 | 0.836 |
PDK1 |
0.689 | -0.026 | 1 | 0.344 |
MEKK6 |
0.688 | 0.013 | 1 | 0.331 |
KHS1 |
0.688 | 0.045 | 1 | 0.311 |
GAK |
0.688 | -0.036 | 1 | 0.388 |
KHS2 |
0.688 | 0.059 | 1 | 0.325 |
SBK |
0.687 | 0.078 | -3 | 0.498 |
HPK1 |
0.687 | 0.000 | 1 | 0.312 |
DCAMKL2 |
0.687 | -0.064 | -3 | 0.677 |
TLK1 |
0.687 | -0.176 | -2 | 0.538 |
MARK1 |
0.687 | -0.069 | 4 | 0.661 |
EEF2K |
0.687 | 0.026 | 3 | 0.821 |
LKB1 |
0.687 | -0.060 | -3 | 0.704 |
NEK11 |
0.686 | -0.073 | 1 | 0.329 |
BRAF |
0.686 | -0.154 | -4 | 0.793 |
HASPIN |
0.686 | 0.043 | -1 | 0.605 |
PKN1 |
0.685 | -0.023 | -3 | 0.613 |
MINK |
0.685 | -0.024 | 1 | 0.298 |
DAPK1 |
0.684 | -0.032 | -3 | 0.682 |
MRCKB |
0.684 | -0.005 | -3 | 0.616 |
ROCK2 |
0.683 | -0.006 | -3 | 0.672 |
SNRK |
0.683 | -0.184 | 2 | 0.590 |
LRRK2 |
0.682 | 0.006 | 2 | 0.749 |
CK2A1 |
0.682 | -0.044 | 1 | 0.253 |
CK1A |
0.681 | 0.036 | -3 | 0.530 |
P70S6K |
0.681 | -0.074 | -3 | 0.597 |
CAMK1D |
0.681 | -0.051 | -3 | 0.571 |
SSTK |
0.681 | -0.110 | 4 | 0.688 |
PBK |
0.681 | -0.012 | 1 | 0.364 |
NEK8 |
0.680 | -0.167 | 2 | 0.726 |
TTBK1 |
0.680 | -0.147 | 2 | 0.550 |
DMPK1 |
0.680 | 0.026 | -3 | 0.647 |
NEK4 |
0.679 | -0.121 | 1 | 0.310 |
CHK2 |
0.678 | -0.019 | -3 | 0.549 |
LOK |
0.678 | -0.079 | -2 | 0.527 |
MRCKA |
0.678 | -0.026 | -3 | 0.631 |
CAMKK1 |
0.678 | -0.215 | -2 | 0.485 |
MST2 |
0.677 | -0.124 | 1 | 0.313 |
VRK1 |
0.677 | -0.095 | 2 | 0.762 |
NEK1 |
0.677 | -0.082 | 1 | 0.309 |
SLK |
0.676 | -0.078 | -2 | 0.497 |
CAMKK2 |
0.676 | -0.185 | -2 | 0.502 |
YANK3 |
0.676 | -0.008 | 2 | 0.366 |
YSK1 |
0.676 | -0.014 | 2 | 0.710 |
CAMK1A |
0.673 | -0.031 | -3 | 0.552 |
TAK1 |
0.673 | -0.179 | 1 | 0.322 |
PDHK3_TYR |
0.672 | 0.176 | 4 | 0.781 |
STK33 |
0.671 | -0.119 | 2 | 0.540 |
PLK2 |
0.671 | -0.089 | -3 | 0.678 |
IRAK1 |
0.671 | -0.221 | -1 | 0.639 |
MYO3B |
0.671 | 0.017 | 2 | 0.736 |
ROCK1 |
0.670 | -0.017 | -3 | 0.633 |
OSR1 |
0.668 | -0.061 | 2 | 0.710 |
PKG1 |
0.668 | -0.056 | -2 | 0.455 |
MST1 |
0.668 | -0.131 | 1 | 0.299 |
BIKE |
0.668 | -0.019 | 1 | 0.359 |
AAK1 |
0.666 | 0.022 | 1 | 0.346 |
CRIK |
0.665 | -0.012 | -3 | 0.613 |
TAO1 |
0.665 | -0.012 | 1 | 0.292 |
PDHK4_TYR |
0.665 | 0.101 | 2 | 0.803 |
MYO3A |
0.665 | -0.006 | 1 | 0.318 |
LIMK2_TYR |
0.665 | 0.142 | -3 | 0.746 |
MAP2K4_TYR |
0.664 | 0.112 | -1 | 0.775 |
ASK1 |
0.664 | -0.037 | 1 | 0.303 |
TTK |
0.663 | -0.086 | -2 | 0.552 |
PKMYT1_TYR |
0.663 | 0.181 | 3 | 0.786 |
NEK3 |
0.663 | -0.107 | 1 | 0.317 |
TESK1_TYR |
0.663 | 0.065 | 3 | 0.822 |
MEK2 |
0.662 | -0.180 | 2 | 0.716 |
ALPHAK3 |
0.661 | -0.053 | -1 | 0.661 |
RIPK2 |
0.661 | -0.209 | 1 | 0.276 |
MAP2K6_TYR |
0.661 | 0.056 | -1 | 0.759 |
PDHK1_TYR |
0.660 | 0.047 | -1 | 0.749 |
MAP2K7_TYR |
0.657 | 0.005 | 2 | 0.769 |
BMPR2_TYR |
0.657 | 0.008 | -1 | 0.754 |
CK1G3 |
0.656 | 0.024 | -3 | 0.493 |
PINK1_TYR |
0.653 | -0.068 | 1 | 0.380 |
LIMK1_TYR |
0.652 | 0.037 | 2 | 0.763 |
RET |
0.651 | -0.081 | 1 | 0.345 |
MST1R |
0.651 | -0.039 | 3 | 0.758 |
CSF1R |
0.650 | -0.012 | 3 | 0.727 |
ABL2 |
0.649 | -0.042 | -1 | 0.681 |
JAK2 |
0.648 | -0.057 | 1 | 0.349 |
EPHB4 |
0.646 | -0.067 | -1 | 0.673 |
TYK2 |
0.646 | -0.118 | 1 | 0.334 |
TXK |
0.646 | -0.037 | 1 | 0.310 |
JAK1 |
0.646 | -0.002 | 1 | 0.304 |
ABL1 |
0.645 | -0.053 | -1 | 0.682 |
ROS1 |
0.645 | -0.060 | 3 | 0.713 |
YANK2 |
0.645 | -0.020 | 2 | 0.383 |
YES1 |
0.644 | -0.064 | -1 | 0.716 |
EPHA6 |
0.644 | -0.093 | -1 | 0.691 |
LCK |
0.644 | -0.042 | -1 | 0.691 |
NEK10_TYR |
0.643 | -0.050 | 1 | 0.288 |
TYRO3 |
0.643 | -0.115 | 3 | 0.740 |
TNNI3K_TYR |
0.642 | 0.008 | 1 | 0.365 |
TNK2 |
0.642 | -0.044 | 3 | 0.698 |
BLK |
0.642 | -0.040 | -1 | 0.692 |
TNK1 |
0.640 | -0.013 | 3 | 0.719 |
JAK3 |
0.640 | -0.103 | 1 | 0.331 |
FGR |
0.639 | -0.134 | 1 | 0.330 |
KIT |
0.639 | -0.080 | 3 | 0.727 |
HCK |
0.639 | -0.102 | -1 | 0.692 |
STLK3 |
0.638 | -0.184 | 1 | 0.281 |
ITK |
0.638 | -0.092 | -1 | 0.671 |
KDR |
0.638 | -0.063 | 3 | 0.677 |
FER |
0.637 | -0.154 | 1 | 0.346 |
WEE1_TYR |
0.637 | -0.027 | -1 | 0.647 |
FGFR2 |
0.637 | -0.060 | 3 | 0.713 |
CK1G2 |
0.637 | 0.002 | -3 | 0.558 |
BMX |
0.636 | -0.066 | -1 | 0.611 |
MET |
0.636 | -0.069 | 3 | 0.726 |
FLT3 |
0.635 | -0.104 | 3 | 0.745 |
DDR1 |
0.635 | -0.138 | 4 | 0.712 |
EPHA4 |
0.634 | -0.083 | 2 | 0.699 |
FYN |
0.633 | -0.060 | -1 | 0.679 |
INSRR |
0.632 | -0.130 | 3 | 0.683 |
SRMS |
0.632 | -0.158 | 1 | 0.312 |
PDGFRB |
0.631 | -0.155 | 3 | 0.741 |
FGFR1 |
0.631 | -0.085 | 3 | 0.688 |
EPHB1 |
0.630 | -0.150 | 1 | 0.314 |
MERTK |
0.630 | -0.132 | 3 | 0.702 |
TEK |
0.629 | -0.069 | 3 | 0.672 |
EPHB2 |
0.629 | -0.141 | -1 | 0.651 |
PDGFRA |
0.628 | -0.127 | 3 | 0.742 |
EPHB3 |
0.628 | -0.149 | -1 | 0.649 |
TEC |
0.628 | -0.117 | -1 | 0.620 |
FLT1 |
0.627 | -0.111 | -1 | 0.676 |
FRK |
0.626 | -0.108 | -1 | 0.679 |
DDR2 |
0.625 | -0.033 | 3 | 0.660 |
FGFR3 |
0.625 | -0.096 | 3 | 0.684 |
MATK |
0.625 | -0.076 | -1 | 0.624 |
AXL |
0.625 | -0.167 | 3 | 0.696 |
BTK |
0.624 | -0.164 | -1 | 0.643 |
ALK |
0.624 | -0.133 | 3 | 0.663 |
LYN |
0.623 | -0.112 | 3 | 0.646 |
EGFR |
0.623 | -0.091 | 1 | 0.252 |
ERBB2 |
0.622 | -0.148 | 1 | 0.298 |
SRC |
0.622 | -0.098 | -1 | 0.687 |
EPHA7 |
0.622 | -0.111 | 2 | 0.692 |
EPHA1 |
0.622 | -0.125 | 3 | 0.714 |
LTK |
0.621 | -0.151 | 3 | 0.671 |
FGFR4 |
0.621 | -0.086 | -1 | 0.644 |
PTK6 |
0.621 | -0.183 | -1 | 0.622 |
PTK2B |
0.621 | -0.101 | -1 | 0.649 |
CSK |
0.620 | -0.085 | 2 | 0.701 |
SYK |
0.620 | -0.079 | -1 | 0.627 |
EPHA3 |
0.619 | -0.140 | 2 | 0.667 |
INSR |
0.618 | -0.142 | 3 | 0.667 |
FLT4 |
0.617 | -0.153 | 3 | 0.664 |
NTRK3 |
0.617 | -0.141 | -1 | 0.638 |
PTK2 |
0.617 | -0.060 | -1 | 0.645 |
NTRK1 |
0.616 | -0.211 | -1 | 0.679 |
EPHA8 |
0.616 | -0.112 | -1 | 0.642 |
ZAP70 |
0.616 | -0.037 | -1 | 0.594 |
NTRK2 |
0.613 | -0.213 | 3 | 0.686 |
EPHA5 |
0.613 | -0.145 | 2 | 0.677 |
ERBB4 |
0.610 | -0.086 | 1 | 0.260 |
MUSK |
0.610 | -0.125 | 1 | 0.244 |
EPHA2 |
0.604 | -0.131 | -1 | 0.619 |
IGF1R |
0.602 | -0.149 | 3 | 0.602 |
FES |
0.596 | -0.125 | -1 | 0.602 |